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Abstract 
 
Phase II metabolites, or conjugates, are highly polar, non-volatile and thermolabile compounds 
that need to be analysed in biological matrices such as urine, bile and plasma. Liquid 
chromatography (LC) and capillary electrophoresis (CE) are proven techniques for the analysis 
of compounds of this kind, but the standard detectors in LC and CE lack sensitivity and 
especially specificity. Coupling of LC or CE to mass spectrometry (MS) provides a powerful 
tool for qualitative and quantitative analysis of drug conjugates. Atmospheric pressure 
ionisation (API) methods produce soft ionisation of the compounds and are well suited for the 
analysis of thermolabile secondary metabolites. 
 
The mass spectrometric and tandem mass spectrometric (MS/MS) behaviour of nitrocatechol-
type glucuronides was systematically studied using atmospheric pressure chemical ionisation 
(APCI) and electrospray ionisation (ESI). The effect of operational parameters on the 
fragmentation of the compounds and the MS and MS/MS spectra is described. The applicability 
of APCI and ESI and a new atmospheric pressure photoionisation (APPI) method for the 
analysis of several phase II metabolites in biological matrices was evaluated. 
 
With the help of enzymatically synthesised standard compounds, three direct methods relying 
on liquid chromatography−tandem mass spectrometry (LC−MS/MS) and capillary 
electrophoresis−tandem mass spectrometry (CE−MS/MS) were developed for the quantitative 
analysis of nitrocatechol glucuronides. ESI in negative ion mode giving deprotonated molecules 
as base peaks in the spectra was found to be the most suitable for the analysis of acidic 
glucuronides. Conditions in the ion source were optimised to produce high abundance of 
deprotonated glucuronide as parent ion, to be fragmented by collision induced dissociation to 
the product ions that were analysed. All methods were based on highly specific selected reaction 
monitoring. 
 
The applicability of the methods was demonstrated in the analysis of intact glucuronides in 
urine and plasma. Urine samples were purified before analysis by simple solid phase extraction 
(SPE). For plasma samples, on-line purification using column-switching technique and 
restricted access material (RAM) column was more effective. All methods were shown to be 
repeatable and sensitive, the limits of quantitation being few femtomoles of glucuronide to MS. 
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1. Introduction 
Drugs are xenobiotic to living organisms and are metabolised by organisms as a protection. 
Drug metabolism reactions are commonly divided into phase I and II reactions. In phase I 
reactions functional groups are added to or generated in the molecule, while in phase II 
reactions the molecule is conjugated with some endogenous species. The most important phase 
II reaction in vertebrates is glucuronic acid conjugation. The others are sulphation, methylation, 
glutathione conjugation and acetylation. 
 
The purpose of conjugation is to inactivate the compound or to make it more readily excretable 
by increasing its water-solubility. Drug conjugates are polar, non-volatile and thermolabile 
compounds, found in biological matrices such as bile, blood and urine. Bioanalysis is an 
important area of research when the metabolic pathways and clinical usefulness of a drug 
candidate need to be assessed. Highly selective and sensitive analytical methods are required in 
these studies. Conjugated products in complex biological matrices must be identified and 
quantitated, preferably without time-consuming pre-treatment of the samples.  
 
Mass spectrometry (MS) providing both qualitative and quantitative information on the analytes 
is needed in bioanalysis. Mass spectra have been widely recorded for the identification of drug 
conjugates in conjunction with liquid chromatographic retention parameters, nuclear magnetic 
resonance spectra and tandem mass spectra (MS/MS). In quantitative analysis the lack of 
commercially available specific standard compounds often complicates the work, so that 
enzymatic or acid hydrolysis of the conjugates to parent compounds is required before the 
analysis. These indirect methods are time-consuming, however, and not always reliable−for 
example if the hydrolysis is incomplete. 
 
In this work, mass spectrometric and tandem mass spectrometric behaviour of synthesised 
glucuronide conjugates of nitrocatechol-type compounds was studied with use of electrospray 
ionisation (ESI) and atmospheric pressure chemical ionisation (APCI) methods (I). Conjugates 
of catechol-type compounds were identified and their amounts in biological matrices were 
compared (II). Direct methods of quantitative analysis relying on hyphenation of liquid 
chromatography (LC) or capillary electrophoresis (CE) with mass spectrometry were optimized 
for nitrocatechol-type glucuronides (III,IV). An LC-MS/MS method utilising a restricted access 
material (RAM) column for on-line sample purification and allowing direct plasma injections 
was developed for the analysis of glucuronide of entacapone in rat plasma (V). 
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2. Review of the literature 
 
2.1. Drug metabolism 
 
Drugs are xenobiotic to living organisms causing organism to biotransform them in various 
ways. Determination of a drug’s fate through its in vivo behaviour is a challenging task for the 
pharmaceutical industry (Clarke et al. 2001). Knowledge of the metabolism of a new drug is 
nevertheless highly important since the metabolism can lead to the production of inactive or 
toxic species, or activate the drug (Clarke and Burchell 1994). Although many drugs are 
extensively excreted unchanged by the kidney, most drugs metabolise before excretion. 
Typically, drug metabolism reactions are divided into phase I and phase II reactions (Gibson 
and Skett, 1994). Phase I reactions, such as oxidation, reduction and hydrolysis, are 
functionalisation reactions in which reactive groups are added to or created in the molecule. 
Phase I reactions prepare the molecule for phase II reactions, conjugative reactions in which 
small endogenous species such as glucuronic acid are attached to the molecule. Compounds are 
usually detoxified in conjugation, become more water-soluble than the original compound and 
are more readily excreted (Clarke and Burchell 1994). 
 
Cytochrome P-450 is the most important and extensively studied enzyme family catalysing 
phase I reactions. Enzymes like UDP-glucuronosyltransferases, sulphotransferases, glutathione-
S-transferases, acetyltransferases and methyltransferases are responsible for phase II reactions. 
The latter enzymes are important in the inactivation of pharmacologically active compounds and 
in detoxifying the carcinogenic and otherwise toxic compounds formed in phase I reactions.  
 
2.2. Glucuronic acid conjugation 
 
Glucuronic acid conjugation is the most common conjugative pathway in drug metabolism and 
drugs from almost all therapeutic classes are glucuronidated (Miners and MacKenzie 1991, 
Clarke and Burchell 1994). There are many reasons for this: the functional groups for 
glucuronidation are numerous, the D-glucuronic acid for the synthesis of co-enzyme, uridine 
5’diphospho-α-D-glucuronic acid (UDPGA), is readily available in all tissues of the body, and 
the water solubility of the conjugated product is greatly increased by glucuronic acid 
conjugation (Low and Castagnoli, 1991). The physiological purpose of glucuronidation is to 
enhance the excretion of such endogenous compounds as steroid hormones, bile acids, thyroid 
hormones and 5-hydroxytryptamine, as well as to terminate the biological activity of 
xenobiotics like drugs (Tukey et al. 2000). Glucuronidation can take place with alcohols, 
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phenols, hydroxylamines and carboxylic acids, with amines and sulphonamides, and with thiols 
with the formation of O-, N- and S-glucuronides, respectively. Glucuronidation is catalysed by 
enzymes of the uridine diphosphate glucuronosyltransferase multigene enzyme family. UDPGA 
provides the glucuronic acid moiety for the reaction, which is a nucleophilic SN2 displacement 
reaction (Fig 1) (Tephly and Burchell, 1990). The products of the reaction are ether or ester 
glucuronides, depending on whether the uridine diphosphate group is replaced by an alkoxyl or 
phenoxy group or by an acyloxy group.  
 
The liver has been established both quantitatively and qualitatively as the most important site 
for glucuronidation (Mulder et al. 1990). Several extra-hepatic tissues also glucuronidate 
compounds, though with more restricted substrate specificity and capacity than hepatic tissue. 
Rat kidney has activity towards phenols and bilirubin but not towards (−)-morphine and 
testosterone, while human kidney does not conjugate bilirubin but is capable of conjugating 
both (+) and (−) enantiomers of morphine (Clarke and Burchell 1994). Phenols, (−)-morphine, 
certain steroids and bilirubin are glucuronidated in the rat gastro-intestinal tract. The tissues 
with high activity to simple phenols are lungs, bronchus, and nasal tissue, while the UGT 
activity found in spleen, thymus, brain and heart is lower (Clarke and Burchell 1994). 
 
Glucuronide conjugation usually leads to inactive products. However, conjugation can also 
convert drug metabolites to compounds that are biologically active or to prodrugs that serve as 
carriers of biological activity to specific tissues (Kauffman et al. 1994). Probably the best 
known example of pharmacologically active glucuronide is 6-O-glucuronide of morphine, 
which is 650 times more potent as an analgesic than is the parent drug (Paul et al. 1989). 
 
Fig. 1. Glucuronidation of morphine catalysed by uridine glucuronosyltransferase. 
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2.3. Sulphate conjugation 
 
Sulphation is a major conjugation pathway for phenols but also occurs for alcohols, amines and 
thiols (Weinshilboum and Otterness 1994). Sulphation enhances the water solubility of most 
compounds and usually results in a decrease in biological activity. As with glucuronide 
conjugation, exceptions to this are well known; for example, sulphate conjugation is necessary 
for activity of minoxidil (Meihseri et al. 1988). In contrast to glucuronidation, the amount of co-
substrate, 3’-phosphoadenosine-5’-phosphosulphate (PAPS), for sulphation may be limited 
(Weinshilboum and Otterness 1994). PAPS is synthesised from inorganic sulphate and 
adenosine triphosphate (ATP) in a two-step process in which the concentration of inorganic 
sulphate may be the limiting factor. This is because a significant amount of the sulphate pool is 
used for the conjugation of endogenous compounds such as steroids, catecholamines, heparin 
and thyroxin. Most drugs and endogenous compounds that can be glucuronidated can also be 
sulphated, and competition for the substrate between the two pathways may result (Mulder et al. 
1990, Gibson and Skett 1994). Sulphate conjugation is considered to predominate in low 
substrate concentration and glucuronidation at high concentration. 
 
2.4. Methylation 
 
The transfer of a methyl group to heteroatoms such as oxygen, nitrogen and sulphur i s catalysed 
by many methyltransferase enzymes (Creveling and Thakker, 1994). Most of the 
methyltransferases are specific for endogenous compounds, but also some exogenous 
compounds can be methylated by non-specific N-methyltransferase found in lung (Gibson and 
Skett 1994). S-Adenosyl-L-methionine is a common methyl donor shared by all enzymes 
catalysing methyl transfer reactions. The co-factor required in methylation processes, S-
adenosylmethionine, is produced under the influence of L-methionine adenosyltransferase from 
L-methionine and ATP. Unlike other conjugation reactions, methylation usually leads to a less 
polar compound and excretion of the drug is hindered (Gibson and Skett 1994). 
 
2.5. Other conjugation reactions 
 
Acetylation, amino acid conjugation, glutathione conjugation and fatty acid or cholesteryl ester 
conjugation are the other phase II reactions. Acetylation reactions are common for aromatic 
amines and sulphonamides (Gibson and Skett 1994). The co-factor required in these reactions, 
acetyl-CoA, can be obtained from the glycolysis pathway or via direct interaction of acetate and 
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coenzyme A. In common with acetate, exogenous carboxylic acids can form CoA derivatives in 
the body and then react with endogenous amines to form conjugates. In this special form of N-
acylation, not the endogenous co-factor but the drug is activated (Gibson and Skett 1994). 
Glycine, glutamine, ornithine, arginine and taurine are common amino acids involved. Many 
drugs are, or can be, metabolised by phase I reactions to strong electrophiles, which can react 
with glutathione to form non-toxic conjugates. These may be excreted directly in urine or may 
further metabolise to cysteine conjugates, and finally, via N-acetylation pathway, yield N-
acetylcysteine conjugate or mercapturic acid. Conjugation of fatty acids, like stearic or palmitic 
acid, takes place, for example, with 11-hydroxy-9∆-tetrahydrocannabinol (Gibson and Skett 
1994).  
 
2.6. Analysis of glucuronide conjugates 
 
Glucuronide conjugates, commonly known as glucuronides, were earlier considered to be 
merely inactive species and less important products of metabolic pathways. Discovery of the 
high activity or toxicity of some glucuronides (e.g. morphine-6-O-glucuronide) has led to 
growing interest in both qualitative and quantitative analysis of glucuronides. Indirect methods 
are often utilised. In such methods, drug metabolites suspected of being glucuronides are 
incubated with a glucuronidase, an enzyme that hydrolyses glucuronide conjugates, and the 
released aglycone is then quantified. An estimate of the extent of formation of glucuronides is 
obtained by summing the amount of unchanged drug and that released from the conjugate. 
Indirect methods are time-consuming, however, and sometimes unreliable, because the 
hydrolysis is incomplete due to inhibiting enzymes present in the matrix. Direct, especially 
quantitative methods of analysis for glucuronides are few, mainly because of the lack of 
commercially available standard compounds. 
 
Analysis of glucuronides is not straightforward. Glucuronides are thermolabile, highly polar, 
non-volatile compounds excreted in complex biological matrices such as urine, blood, bile, 
cerebrospinal fluid and faeces. Thus separation from the disturbing matrix compounds is 
required before detection. The amount of glucuronide may also be extremely low, as, for 
example, at the end of a pharmacokinetic series, so that extremely high sensitivity is required of 
the analytical method. A variety of methods have been developed for the analysis of 
glucuronides (Bedford 1998). Techniques, such as gas chromatography, in which high 
temperatures are used are inappropriate because glucuronides are thermolabile. Capillary 
electrophoresis is particularly good technique for the analysis of polar compounds, like 
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glucuronides, and has recently attracted growing interest (Bedford 1998, Boone et al. 1999, 
Ding and Vouros 1999, Heitmeier and Blaschke 1999, Wey et al. 2000, Meier and Blaschke 
2000). A major technique for the determination of non-volatile, polar and water-soluble 
glucuronides is liquid chromatography. Liquid chromatography with ultraviolet (UV) or 
fluorimetric detection is included in about 80% of references cited in a review of analytical 
methods for glucuronic acid conjugates (Bedford 1998). The most commonly used stationary 
phase in LC analysis of glucuronides is unpolar octadecylsilane or octylsilane with mobile 
phase consisting of acetonitrile and acidic buffer species (pH 1.8-4.0) in reversed phase mode. 
Relatively low pH ensures protonation of carboxylic acid in glucuronide moiety and ensures 
good chromatography of the compounds (Bedford 1998). Limitations of the technique are 
mostly related to detection: poor sensitivity because of the aglycone structure or poor selectivity 
of the standard LC detectors.  
 
2.6.1. Liquid chromatography−mass spectrometry 
 
Coupling of LC to mass spectrometry provides additional sensitivity and most notably, high 
selectivity for the analysis of drug conjugates (Baillie 1992). Early work in mass spectrometric 
analysis of glucuronides was done using ionisation methods such as electron impact and 
chemical ionisation (Perchalski et al. 1982, Bruins 1981), thermospray (TSP) (Liberato et al. 
1983, Rudewicz and Straub 1986) and fast atom bombardment (FAB) (Rudewicz and Straub 
1986, Fenselau et al. 1984). In the late 80’s and early 90’s, the majority of glucuronide studies 
employed TSP-LC−MS and FAB-MS, as reviewed by Baillie in 1992. The sensitivity of these 
techniques is highly dependent upon analyte type, however, and TSP mass spectra are often 
affected by temperatures at the interface. Introduction of atmospheric pressure ionisation (API) 
techniques, in which the eluent from LC is nebulized the ion source at atmospheric pressure, has 
made coupling of LC to MS easy and nowadays practically all LC−MS methods, including 
those in glucuronide analysis, rely on these ionisation techniques (Niessen 2000). Interfaces for 
atmospheric pressure chemical ionisation and electrospray ionisation are compatible with 
reversed-phase solvent systems, suitable for a wide range of structural types, easy to operate, 
and available from all major mass spectrometer manufacturers. More recently a new interface, 
based on atmospheric pressure photoionisation (APPI), has been introduced to the market (Robb 
et al. 2000).  
 
API techniques are soft ionisation methods that yield abundant even-electron parent ions 
([M+H]+ or [M-H]-), which indicate the molecular weight of the unknown compound. The 
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spectra obtained by soft ionisation methods often suffer from the absence of significant 
fragment ions, but this problem can be solved by the use of tandem mass spectrometry. MS/MS 
is an irreplaceable tool in the structure elucidation of drug metabolites and utilised also in the 
“metabolic mapping” of drug substances as first outlined in 1982 (Perchalski et al. 1982) and 
further developed shortly thereafter (Rudewicz and Straub 1986). In the “metabolic mapping” 
procedure, possible metabolites are searched by precursor ion scanning or neutral loss scanning 
in collision induced dissociation (CID) conditions. The parent ion found with this procedure is 
selected for CID and the molecular structure of the compound is further confirmed by a 
daughter ion spectrum. 
 
Electrospray ionisation 
 
Electrospray mass spectrometry was first introduced in 1984 (Yamasita and Fenn 1984a,b), 
though some early experiments were made in 1968 (Dole 1968). In this technique the ions are 
formed primarily in the liquid-phase and the solution is passed through a small diameter (i.d. 0.1 
mm) capillary held at high potential (3-6 kV) to the ion source. Because the capillary tip is very 
narrow, the electric field in the air at the capillary tip is very high (Kebarle and Tang 1993). 
This field partially penetrates the liquid at the capillary tip. If a positive potential is set to the 
capillary, positive ions in the liquid will drift towards the liquid surface, while negative ions 
drift away from it. As a result, the positively charged surface is drawn outfield such that a liquid 
cone, called Taylor cone, which emits a fine spray of positively charged droplets, is formed. 
Two models have been presented for the mechanism by which the ions are formed from the 
spray: the charged-residue model, also called the single ion in droplet theory (Dole et al. 1968), 
and the ion-evaporation concept of Iribarne and Thomson (Iribarne and Thomson 1976).  
 
The stability of the electrospray process is limited to flow rates of 5-10 µl/min (Yamasita and 
Fenn 1984, Whitehouse et al. 1985). This requires significant splitting of the flow when the 
interface is used to couple conventional 4.6 mm I.D. LC columns. Formation of the spray can be 
improved, and thus the flow rate increased, by pneumatically assisting the nebulisation with a 
method called ionspray (Bruins et al. 1987). This interface design allows the use of moderate 
voltages and eluents with high water content or higher flow rates (50-200 µl/min). Also various 
other approaches have been used to avoid splitting, among them thermally assisted electrospray 
(Lee and Henion 1992), ultrasonically assisted electrospray (Banks et al. 1994a,b), multiple 
sprayers in pneumatically assisted electrospray (Kostiainen and Bruins 1994, Shia and Wang 
1997), electrospray needle with heated tip (Ikonomou and Kebarle 1994) and orthogonal spray 
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(Hiraoka et al. 1994). The turbo-ionspray is a commercially available electrospray interface in 
which additional heated desolvation gas is directed to the ion source to assist the evaporation of 
the solvent. Use of this gas makes it possible to increase the f low rate up to 1 ml/min. However, 
under API conditions the mass spectrometer is generally considered to act as a concentration-
sensitive device, that is, the response of the detector is independent of the flow-rate (Kebarle 
and Tang 1993, Hopfgartner et al. 1993, Bruins 1998), and thus the need for such capacity is 
questionable.  
Fig. 2. Schematic drawing of an electrospray ion source. 
 
As is evident from the theory presented above, only polar eluents capable of conducting 
electricity and volatile buffer species are compatible with ESI. Non-volatile buffers cause 
contamination of the instrument in long-term use and may even lead to a total plugging of the 
system. Improvements in interfaces, such as orthogonal or Z-sprayers creating an off-axis ion 
pathway (Yu and Balogh 2001), and an interface with a self-cleaning solvent delivery system 
(Rao 2001), have been developed to minimise this problem. However, routine, long-term use of 
non-volatile buffer species, such as phosphates or ion-pairing agents, is probably not possible. 
Some solutions such as on-line continuous-flow liquid-liquid extraction, coupled-column and 
valve switching techniques, and application of micromembrane suppressors have been 
developed to solve this incompatibility problem (Niessen and Tinke 1995). More often, volatile 
additives such as formic acid, acetic acid, ammonium hydroxide and ammonium acetate are 
used for pH adjustment. 
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Atmospheric pressure chemical ionisation 
 
The coupling of LC to MS through a heated nebulizer interface was demonstrated by Horning’s 
group in 1974 (Horning et al. 1974, Carroll et al. 1975). In this interface the sample is 
introduced to the ion source in an eluent flow surrounded by a flow of carrier gas. The eluent is 
vaporised with the help of heat, making possible the use of a higher flow rate than in ESI. The 
vaporised sample molecules are ionised in the APCI source as in normal chemical ionisation. 
The major primary ions are formed by electron impact of corona-created electrons of the major 
neutral components in the air (Horning et al. 1974). These ions react extremely rapidly to form 
protonated eluent molecules, which react with the analytes by charge exchange or proton 
transfer.  
 
In charge exchange reactions a charge from a positive ion is transferred to a neutral molecule. 
Charge exchange reactions can occur if the recombinant energy of the reactant ion is greater 
than the ionisation energy of the neutral molecule. Charge exchange reactions are expected for 
nonbasic compounds with ionisation potential lower than that of benzene (Horning et al. 1973). 
Ionisation of basic drugs is mainly due to proton transfer reaction, which is the main reaction in 
positive ion chemical ionisation (Harrison 1982). Proton transfer reaction is exothermic and 
efficient if the proton affinity (PA) of the analyte is higher than that of the eluent molecule. The 
greater the difference in the PA values, the more exothermic is the reaction and the more 
internal energy is transferred to the analyte, leading to stronger fragmentation. Proton transfer 
reactions are also important in negative ion mode, where deprotonated molecules are produced. 
In deprotonation a proton is transferred from the analyte to the deprotonated eluent molecule if 
the PA of the deprotonated eluent molecule is higher than that of the deprotonated analyte. 
Ionisation in negative ion mode APCI may also occur by electron capture, on condition that the 
analyte has a free orbital for the electron. Adding suitable chemical ionisation reagents, such as 
ammonia, to the eluent may enhance ionisation in APCI. 
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Fig. 3. Schematic drawing of a heated nebulizer interface. 
 
Atmospheric pressure photoionisation 
 
The interface used in APPI ionisation is a heated nebulizer interface in which the corona needle 
is replaced by a photoionisation lamp. The initial reaction is formation of a radical cation of the 
dopant molecule, e.g. acetone or toluene, due to the photons emitted by the photoionisation 
lamp (Robb et al. 2000, Koster and Bruins 2001, Kauppila et al. 2001). If PA of the eluent 
molecules is higher than that of benzyl radical (831.4 kJ/mol) (NIST Chemistry WebBook, 
2001), the radical cation reacts with the eluent molecules producing protonated eluent 
molecules. If the PA of the analyte is higher than that of the eluent molecule the analyte is 
ionised in the proton transfer reaction. Alternatively, if the PA of the eluent molecules is lower 
than that of the benzyl radical, the charge exchange reaction between the radical cation and 
analyte is favoured, but only if the recombination energy of the analyte is lower than that of the 
radical cation. Deprotonation and charge exchange reactions are also possible in APPI 
(Kauppila et al. 2001). 
 
Qualitative LC−MS in glucuronide analysis 
 
LC−MS is routinely applied in metabolic studies to the identification or characterisation of 
glucuronides as well as other drug metabolites; examples of these applications are presented in 
Table 1. Studies concerning the metabolic fate of drugs can be divided into three types: 
elucidation of biotransformation pathways of a drug through identification of excreted 
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metabolites, disposition studies involving determination of pharmacokinetic parameters for a 
drug or its metabolites, and identification of chemically reactive metabolites (Baillie 1992). 
Metabolism of a drug candidate can be investigated in in vitro or in vivo experiments. The 
results, however, may vary with the model, as occurred, for example, in work by Higashi et al. 
in 1999. 24,25-Dihydroxyvitamin D3, a metabolite of vitamin D3 being examined as an anti-
osteoporosis medicine, was found to give 3- and 24-glucuronides in equal amount as the main 
products in the presence of rat liver microsomal fraction, and only a small amount of the 
corresponding 25-glucuronide was obtained. After administration of 24,25-dihydroxyvitamin D3 
to rats, in vivo, glucuronidation was found to occur at the 24-position in preference to the 3-
position, and the 25-glucuronide was not detected at all.  
 
A typical example of the use of LC−MS in pharmacokinetic studies is a study of in vitro 
glucuronidation of anticonvulsant D-23129 by human microsomes and liver slices (McNeilly et 
al. 1997). In this work, the metabolites that formed were identified by LC−ESI-MS, and the 
apparent Km was determined for one of the glucuronides. The necessity of knowing the complete 
metabolic profile of a new drug was illustrated by the differences found in the in vitro 
metabolisms of D-23129 and flupirtine, which differ in a single atom. Bioactivation of a toxic 
metabolite of valproic acid via glucuronidation to further conjugate with GSH was 
demonstrated in work of Tang and Abbot in 1996. The GSH-glucuronide diconjugates of (E)-
2,4-diene valproic acid characterised with LC−MS/MS and 1H-NMR were suggested to be 
significant to further understanding of the potential mechanism for hepatotoxicity of valproic 
acid. 
 
In addition to the above-mentioned applications, LC−MS has been used for the characterisation 
of synthesised steroid glucuronides. The synthesis products are 5α-androstane-3α,17β-diol,17β-
glucuronide (Chung et al. 1992), [16,16,17,2H3]-testosterone and –epitestosterone glucuronides 
(Sanaullah and Bowers 1995), and enzymatically synthesised glucuronide conjugates of 5α-
estran-3α-ol-17-one, 5β- estran-3α-ol-17-one, 17α-methyl-5α-androstane-3α,17β-diol and 
17α-methyl-5β-androstane-3α,17β-diol (Kuuranne et al. 2000).  
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Table 1. Qualitative LC−MS applications in glucuronide analysis. 
Compound Sample matrix Ionisation Reference 
Dolasetron human urine pos ESI Ackermann et al. 1996 
Olanzapine human urine, human serum pos APCI Bogusz et al. 1999 
Flunixin dog urine pos ESI Brady et al. 1998 
S12813 (analgesic) rat liver slices pos ESI Brownsill et al. 1994 
Azaperone equine urine pos APCI Chui et al. 1994 
Ibuprofen human urine neg ESI Clayton et al. 1998 
19-nortestosterone laurate bovine hepatocytes pos ESI Coldham et al. 1998 
51W89 (neuromuscular 
blocker) 
cat, dog, and human urine, 
cat and dog bile 
 
neg ESI, pos ESI 
 
Dear et al. 1995 
Soy isoflavone human colon microsomes, 
human blood 
 
pos ESI 
 
Doerge et al. 2000 
LY335979 human microsomes, rat bile pos ESI Ehlhardt et al. 1998 
Propofol human urine neg APCI Favetta et al. 2000a 
Propofol human urine neg ESI, pos ESI Favetta et al. 2000b 
SFZ-47 (anti-inflammatoric), 
etofesalamide, propafenone, 
5-hydroxypropafenone 
 
 
human urine 
 
 
neg ESI 
 
 
Gu et al. 1999 
Prostaglandin E2 rat hepatocytes neg ESI Hankin et al. 1997 
Benztropine rat urine, rat bile pos ESI He et al. 1995 
24,25-dihydroxyvitamin D3 rat liver microsomes, rat 
bile 
 
neg ESI, pos ESI 
 
Higashi et al. 1999 
24,25-dihydroxyvitamin D3, 
25-hydroxyvitamin D3 
 
rat bile 
 
neg ESI, pos ESI 
 
Higashi et al. 2000 
Ibuprofen human urine neg ESI Ikegawa et al. 1998 
Olanzapine human plasma, urine, faeces pos ESI Kassahun et al. 1997 
32Ifetroban buffer solutions pos ESI Khan et al. 1998 
NK-104 (HMG-CoA 
reductase inhibitor) 
 
rat, rabbit and dog bile 
 
pos ESI 
 
Kojima et al. 1999 
Candesartan cilexetil rat plasma pos ESI Kondo et al. 1996 
Tea catechins human urine  neg ESI Li et al. 2001 
Clozapine human urine pos ESI Luo et al. 1994 
Carbamazepine human urine pos ESI Maggs et al. 1997 
D-23129 (anticonvulsant) human liver microsomes 
and liver slices 
 
neg ESI, pos ESI 
 
McNeilly et al. 1997 
Efavirenz rat bile neg ESI Mutlib et al. 1999 
14C-Bromfenac  monkey urine neg ESI Osman et al. 1998 
CP-93,393 (antianxiety) rat urine, bile, plasma pos ESI Prakash and Soliman 
1997 
[3H]formoterol human urine pos ESI Rosenborg et al. 1999 
Clozapine human urine neg ESI, pos ESI Schaber et al. 2001 
Talinolol human, dog, rat and mouse 
urine 
neg ESI, pos ESI, pos 
TSP 
 
Schupke et al. 1996 
Vitamin D2, 25-
hydroxyvitamin D2 
 
rat bile 
 
neg APCI, pos APCI 
 
Shimada et al. 1997 
Acetaminophen human urine pos ESI Shockor et al. 1996 
Clofibric acid incubation mixture, rat bile pos ESI Shore et al. 1995 
Naproxen human urine neg APCI Sidelmann et al. 2001 
Lamotrigine human urine pos ESI Sinz and Remmel 1991 
U-91502 (bisphosphonate 
ester) 
 
rat urine, rat bile 
 
pos ESI,  
 
Slatter et al. 1995 
Valproic acid rat bile pos ESI Tang and Abbott 1996 
Eltanolone dog urine neg ESI Tjernberg et al. 1998 
Quercetin human plasma pos ESI Wittig et al. 2001 
Benzo[a]pyrene rat urine neg ESI Yang et al. 1999 
Daidzin, daidzein rat urine, rat bile neg ESI Yasuda et al. 1994 
Vintoperol rat bile, dog urine pos ESI Yoshitsugu et al. 1999 
Clozapine rat urine, rat bile neg ESI, pos ESI Zhang et al. 1996 
Celecoxib rabbit urine neg ESI Zhang et al. 2000 
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Quantitative LC−MS in glucuronide analysis 
 
Although LC−MS is routinely used in the identification and characterisation of glucuronides, 
direct, quantitative methods for glucuronides are few. Most quantitative methods rely on ESI 
since it operates without heat input in the spray-ionisation step, thus allowing the labile and 
polar glucuronides to be ionised without thermal degradation (Whitehouse et al. 1985). The 
majority of the direct methods described in the literature have been developed for the 
quantitation of biologically active morphine 3-β-D- (M3G) and morphine 6-β-D-glucuronides 
(M6G) in serum, plasma or urine. These glucuronides are metabolites not only of morphine but 
also of codeine and abused illegal diacetylmorphine (heroin). Analysis of these compounds is 
important in pharmacokinetic studies and in routine analysis of drugs of abuse in forensic 
toxicology.  
 
The methods developed for the analysis are based on single ion monitoring (Dienes-Nagy et al. 
1999, Pacifici et al. 1995, Tyrefors et al. 1996, Zuccaro et al. 1997, Schänzle et al. 1999) or 
selected reaction monitoring in LC−ESI-MS/MS (Zheng et al. 1998, Blanchet et al. 1999, 
Naidong et al. 1999, Slawson et al. 1999, Shou et al. 2002). Sensitivity of the methods varies, 
the limit of quantitation for M3G is between 0.25 ng/ml (Slawson et al. 1999) and 100 ng/ml 
(Pacifici et al. 1995). The majority of the assays for M3G and M6G rely on reversed phase 
chromatography with acidic eluents. This is because morphine contains an amino group suitable 
for protonation, and ionisation in positive ion mode is thus easily achieved. To obtain 
reasonable retention of morphine and its glucuronides in reversed phase material is complicated 
by the highly polar nature of the compounds, even in neutral form. Two of the assays are based 
on normal phase columns, which are able to retain polar compounds even with eluents of high 
concentration of organic solvent (Zuccaro et al. 1997, Naidong et al. 1999). The advantage of a 
high percentage of organic solvent is lowered surface tension of the eluent and thus enhanced 
spray formation and sensitivity of the method during the ESI process. The use of a phenyl 
column is also possible (Zheng et al. 1998).  
 
Testosterone (T) and epitestosterone (E) are endogenous steroids that yield glucuronide (TG, 
EG) and sulphate conjugates in urine. Detection of testosterone abuse in athletes starts from the 
knowledge that the normal ratio (T/E) of these compounds excreted in human urine is below 6. 
Direct LC−ESI-MS/MS methods for the quantitation of intact glucuronides at low nanomolar 
range have been developed in order to improve the reliability of the determination of this ratio 
(Bean and Henion 1997, Borts and Bowers 2000). Direct quantitation of EG and TG is also 
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possible with a method presented in 1996 by Bowers and Sanaullah. The method is suitable as 
well for the analysis of androsterone, ethiocolanone and epiandrosterone glucuronides.  
 
Certain steroids need to be measured in clinical studies. An LC−MS method was recently 
developed for quantitation of 17-ketosteroid conjugates in human urine (Jia et al. 2001). The 
method was developed as a means of generating reference values to be used in research 
regarding the relation between steroids and ageing or disease as well as monitoring of steroid 
abuse in sports. Separation of 17-ketosteroid conjugates−glucuronides and sulphates of 
dehydroepiandrosterone, epiandrosterone and etiocholanol-17-one−was achieved by using a 
high concentration (0.1 M) of ammonium acetate buffer. ESI was found inappropriate because 
the high concentration of buffer led to significant signal loss. Sonic spray ionisation (SSI), 
which was found to be over 20 times more sensitive than ESI, was chosen for the analysis. The 
limit of quantitation for 17-ketosteroid glucuronides was 3-30 ng/ml and 1450-2000 ng/ml 
under SSI and ESI conditions, respectively. 
 
Other, miscellaneous quantitative ESI methods have been published. An LC-ESI-MS method 
for the determination of ethyl glucuronide (EtG), a minor metabolite of ethanol, is useful for 
forensic chemists and for police monitoring driver inebriation, since EtG is detectable up to 8 h 
after complete ethanol degradation (Nishikawa et al. 1999). The detection limit of the method 
was 30 ng/ml in the selected ion monitoring mode. Diastereoisomeric glucuronides of 
propafenone, an antiarrhythmic agent, were quantitated in human plasma and urine by an 
LC−ESI-MS method developed for a pharmacokinetic study assessing the influence of 
rifampicin on propafenone disposition (Hofmann et al. 2000). Naphthalene metabolites were 
determined in human urine under ion-suppressed reversed phase conditions (Andreoli et al. 
1999). The mobile phase for gradient analysis was prepared of 2 mM aqueous formic acid and 
methanol in order to prevent ionisation of the analytes on reversed phase column during high 
speed separation. The ionisation of naphthalene metabolites, i.e., α-naphthol, α-
naphthylglucuronide and β-naphthylsulphate, was obtained in negative ion mode. The limit of 
detection for α-naphthylglucuronide was 20 ng/ml. Buprenorphine (BUP) is a semi-synthetic 
opiate used, for example, for the treatment of opioid dependence. Recently detected BUP-
related deaths have raised concern about the possible abuse and misuse of this compound. With 
an LC−ESI-MS/MS method developed for the simultaneous determination of BUP, 
norbuprenorphine and BUP-glucuronide in plasma, the analysis of the compounds is simplified 
and the analysis time shortened relative to earlier methods. The limit of quantitation was 0.1 
ng/ml for the three analytes (Polettini and Huestis 2001). Glucuronides are found not only in 
 21
biomatrices of animals but also in plant material. Major active compounds of Erigeron 
breviscapus, a medicinal herb used for the treatment of paralysis caused by cerebral vascular 
accidents, have been identified as glucuronides. An LC−ESI-MS/MS method was recently 
developed for the search, structural elucidation and quantitation of the glycosides, among them 
apigenin-7-O- and quercetin-3-O-glucuronides, in this plant material. The limit of detection was 
30 and 110 pg/ml for apigenin-7-O- and quercetin-3-O-glucuronide, respectively (Qu et al. 
2001). 
 
All the above methods utilise commercially available or synthesised standard compounds for 
quantitation. In a study of n-hexane metabolites, however, it was found that the response for the 
glucuronides of phenol, aniline, naphthol and p-nitrophenol in negative-ion ESI-MS is only 
slightly affected by the structure of the aglycone part, but fully determined by the glucuronic 
acid moiety. This suggests that at least semi-quantitative determination of the glucuronide 
conjugates can be achieved without standard compounds (Manini et al. 1998a). This is possible 
only in ESI, however; in APCI the structure of the aglycone has some effect on the response 
(Manini et al. 1998b).  
 
Few quantitative LC−MS methods have been based on atmospheric pressure chemical 
ionisation. APCI has been utilised in quantitative analysis of the glucuronides of codeine, heroin 
and morphine (Bogusz et al. 1997a, 1997b) and in determination of the glucuronides of 
aminophenyl, phenyl, nitrophenyl and α-naphthyl (Manini et al. 1998b). The probable reason 
why APCI is less frequently used than ESI is that glucuronides partially dissociate to aglycones 
in the heated nebulizer interface (Chui et al. 1994). Dissociation was also detected by a group 
that developed a direct method for quantitation of heroin metabolites in post-mortem biological 
fluids (Boguz et al. 1997a). The limit of detection with their LC−APCI-MS method was 1 ng/ml 
for M3G and M6G, which is highly comparable with ESI-MS methods for the compounds. In 
other work by the same group, the extent of fragmentation of morphine glucuronides was found 
depend on the composition of the mobile phase: the higher the concentration of organic solvent 
(acetonitrile) in the mobile phase, the greater was the fragmentation (Boguz et al. 1997b). This 
contrasts with later observations that the fragmentation of glucuronides is stable and 
independent of the composition of the mobile phase when the concentration of acetonitrile is 
varied between 0 and 90% (Dienes-Nagy et al. 1999). 
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2.6.2. Capillary electrophoresis−mass spectrometry 
 
Capillary electrophoresis was originally introduced in 1967 (Hjertén 1967). Interest has grown 
particularly since 1981 when a paper on CE employing narrow capillaries was published 
(Jörgenson and Lukacs 1981). The technique is based on the separation of charged analytes in 
narrow bore capillaries (i.d. 10-100 µm) of small volume (1-2 µl) under the influence of an 
electric field (10-30 kV). It can be employed in different modes of operation with different 
separation principles: capillary zone electrophoresis, micellar electrokinetic chromatography, 
isotacophoresis, capillary electrokinetic chromatography, capillary gel electrophoresis and 
isoelectric focusing (Boone et al. 1999). Different modes are chosen simply by selecting 
appropriate pH and type and concentration of buffer or the separation media. Samples are 
loaded to the capillary by hydrodynamic, vacuum or electrokinetic injection and the detection of 
the separated zones is usually performed on-line in capillary. 
 
CE has several interesting features that make it useful for the analysis of charged compounds in 
biological samples. Probably that most often mentioned is the high separation efficiency; 
theoretical plate values up to 1.5×106 have been measured (Kuhr 1990). Other features of CE 
are easily optimised resolution, small dead volume, minimal consumption of eluents and 
minimal amount of sample to be injected. The small sample volume is also a major drawback of 
the system: optimal separation efficiency can be achieved only if the loading volume is below 
2% of the total capillary volume (Cai and El Rassi 1992), which means injection volumes of 1-
100 nl. And this inevitably means poor sensitivity, especially when dilute solutions or low 
concentrations of metabolites in biological matrices are to be analysed. Many solutions have 
been developed to overcome this problem, including concentrative injection techniques, on-line 
sample preconcentration, wide-bore capillaries and modified capillaries (Altria 1999).  
 
MS detection for CE has been actively pursued in recent years not only because MS improves 
detection limits in comparison with UV, but also because the selectivity and specificity of MS 
compensate for variations in migration times of the analytes (Ding and Vouros 1999). Capillary 
electrophoresis−mass spectrometry (CE−MS) was first introduced in 1987 (Olivares et al. 
1987). Coupling of the instruments is usually achieved with an electrospray interface using 
coaxial sheath liquid (Smith et al. 1988) or with a liquid junction coupling (Lee et al. 1989). 
Sheathless coupling with a nanospray interface may provide better limits of detection because 
dilution of samples is avoided. New, more simple and robust interface designs (Moini 2001) as 
well as new coating materials (Nilsson et al. 2001) for sheathless coupling have recently been 
 23
developed. With an interface using a split-flow technique there is no dead volume and the 
bubble formation due to redox reactions of water at the electrode was found to have no effect on 
CE−ESI-MS performance (Moini 2000). New coating material, a graphite-polyimide mixture, 
was shown to have a good performance during oxidative stress and to be stable up to two weeks 
(Nilsson et al. 2001). However, sheathless coupling probably is not yet sufficiently robust for 
extended routine analysis. 
 
CE−MS applications in glucuronide analysis 
 
CE−MS is a highly promising technique for the bioanalysis of drugs owing to the high 
separation power of CE and the high specificity of MS. Though the technique has been applied 
in the bioanalysis of many drugs, the analysis of drug metabolites is still unusual. In particular, 
glucuronides, whose ionic characters makes them ideal compounds for analysis with this 
technique, are seldom analysed in this way (Boone et al. 1999, von Brocke et al. 2001). A 
CE−MS screening method has been developed for the analysis of non-opioid analgesics and 
their metabolites in urine (Heitmeier and Blaschke 1999), and a preliminary confirmatory assay 
has been published for codeine, dihydrocodeine and their glucuronides in human urine (Wey et 
al. 2000). Mono- and dihydroxyglucuronides of praziquantel, a drug for the treatment of human 
schistosomiasis, were qualitatively determined in human urine by CE−MS (Meier and Blaschke 
2000). It is strange that the glucuronides were not separated during CE−MS analysis, though 
they had different masses. CE−MS and µ-LC−MS methods were compared in the analysis of 
midazolam and three of its metabolites, one of them the glucuronide (Lausecker et al. 1998). 
The sensitivity of the CE−MS method for the glucuronide proved to be almost 10 times better 
than that of the µ-LC−MS method, the limit of detection being just 19 pmol of glucuronide 
injected. With the same amount of analyte introduced to the mass spectrometer, CE yields 
sharper peaks and thus better sensitivity for MS detection (Ding and Vouros 1999). The very 
high efficiencies achieved in CE can, however, cause severe problems for MS detection. This is 
because the scanning speed of MS instruments, especially quadrupoles, is low and it is difficult 
to obtain reliable spectra of very narrow peaks. 
 
2.7. Sample pre-treatment 
 
The biological matrices in which glucuronides need to be analysed contain interfering 
compounds in high concentrations, which may distort the separation in chromatography or 
suppress the ionisation process in mass spectrometry. Disturbing matrix compounds must be 
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removed in sample pre-treatment, not only to avoid clogging of columns and capillaries but also 
to improve the selectivity, accuracy, reliability, and repeatability of analyse. Analytes are often 
concentrated in the pre-treatment procedure and the sensitivity of the method is thus improved. 
Common pre-treatment methods for biological samples include filtration, protein precipitation, 
liquid-liquid extraction, solid-phase extraction (SPE), dialysis and centrifugation. Of these 
methods, SPE has achieved the widest acceptance owing to the ease of automation, high analyte 
recovery, extraction reproducibility, facility for selective increase of the analyte concentration, 
the commercial availability of SPE devices and the wide variety of SPE sorbents (Gilar et al. 
2001). Manual methods increase the risk of contamination and sources of error, however, and 
much interest is therefore being shown in the development of automated on-line sample pre-
treatment methods, such as column switching technique. 
 
Restricted access media (RAM) are a class of column packing materials that were developed to 
allow direct injection of untreated plasma and other biological fluids. A comprehensive review 
of these materials has been published in 1998 (Boos and Rudolphi 1998a). Although RAM 
materials are prepared by a variety of methods, the principle of their operation is the same: large 
molecules such as proteins only reach the hydrophilic, non-absorptive layers on the outer 
surface of silica particles and are eluted in a column void volume; small analyte molecules, in 
turn, penetrate the outer surface, reach the adsorption sites and are retained. The access of 
proteins to the inner pores is prevented by a physical diffusion barrier with an appropriate pore 
diameter (6 nm) or by a chemical barrier of an appropriate polymer at the outer surface of the 
particles preventing adsorption or denaturation of macromolecules. Restricted-access media can 
be further subdivided with respect to the topochemistry of the bonded phase (Boos and 
Rudolphi 1998a). Internal surface reversed-phase supports (ISRP) are the most popular RAMs 
(Hennion 1999). In ISRP, supports the internal pore surface of a glyceryl-modified silica is 
covered with a bonded C4, C8 or C18 reversed phase. These sorbents are also known as alkyl-diol 
silica. 
 
RAM columns have great potential as precolumns for use in on-line analysis with column-
switching or hyphenated techniques (Boos and Rudolphi 1998b). A column-switching set-up 
requires the addition of an HPLC pump and a six-port switching-valve to the normal HPLC 
system (Figure 4). The analytical procedure utilising column-switching can be divided into three 
steps: sample application and fractionation, transfer of the analyte fraction to the analytical 
column and separation of the analytes. Each of these steps requires careful optimisation. The 
sample in a biological matrix is loaded onto a RAM column in valve position A (Figure 4a). 
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Analytes of interest are retained on the pores of the packing material, while proteins and other 
large matrix compounds are flushed with the loading eluent to waste. All the matrix compounds 
should have been washed to the waste before the valve is rotated to position B (Figure 4b). 
After this switch the analytes are back-flushed onto the separation column with a mobile phase 
of stronger eluting power. The valve is switched back to its original position (Figure 4a) after 
complete transfer of the analyte fraction. The RAM column is washed and re-equilibrated with 
the solvents delivered by the first pump, and the next sample can be loaded while the first 
sample is still being analysed. 
 
 
Fig. 4. Set-up of a column switching system. Position a) is used in sample application and 
fractionation, and during the separation, while position b) is used for transfer of the analytes. 
 
The valve switching times are critical parameters in developing a successful column-switching 
method. The times can be calculated by determining the time of complete elution of the sample 
matrix (tM), breakthrough time of the analytes (tA), and the time of complete elution (transfer) of 
the analytes (tT) (Majors et al. 1996). After determination of these factors the valve switching 
times are calculated with the help of the following simple formulas: 
 
 tV1 = end of sample fractionation 
  tA < 10 min  tV1 = ½ (tM + tA), flow rate 0.8 ml/min 
  tA > 10 min tV1 = (tM + 5 min), flow rate 0.8 ml/min 
 
 tV2 = end of transfer 
  tV2 = (tT + 1 min), flow rate 1.0 ml/min 
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In drug analysis as elsewhere, an increasing number of applications now rely on RAM materials 
(Boos and Schäfer 2000). No applications were found for the quantitation of glucuronides, 
however. 
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3. Aims of the study 
 
The primary aim of the study was to evaluate the applicability of liquid chromatography−mass 
spectrometry and capillary electrophoresis−mass spectrometry for the analysis of drug 
conjugates in biological matrices. 
 
Specifically, the aims of the research were 
 
- to study mass spectrometric and tandem mass spectrometric behaviour of nitrocatechol-type 
glucuronides subjected to different ionisation methods (I) 
- to determine the optimal ionisation method for glucuronides as well as other drug 
conjugates (I,II) 
- to develop direct and fast quantitative methods of analysis for glucuronide conjugates in 
biological matrices (III-V) 
- to study and simplify pre-treatment of biological samples in MS and LC−MS (I,V) 
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4. Materials and methods 
 
Materials, samples, instrumentation and analytical conditions are briefly described in this 
section. More detailed descriptions can be found in the original publications I-V. 
 
4.1. Reagents and samples 
 
Chemicals and standard compounds used in this study are listed in Table 2. Structures of the 
studied compounds are presented in Figure 5. 
 
Table 2. Reagents used in the study. 
Compound Source 
Acetic acid Rathburn 
Acetonitrile Rathburn 
Ammonium acetate Merck 
Ammonium hydroxide Merck 
Apomorphine hydrochloride Sigma Chemical C.O. 
3,4-dihydroxy-5-nitrobenzaldehyde glucuronide (AG) Division of Pharmaceutical Chemistry* 
Dobutamine hydrochloride Eli Lilly Company 
Entacapone Orion Pharma 
E-Entacapone glucuronide (EEG) Division of Pharmaceutical Chemistry’ 
Z-Entacapone glucuronide (EZG), Division of Pharmaceutical Chemistry* 
Formic acid  Merck 
Hydrochloric acid Merck 
Hydroxypropyl-β-cyclodextrin (HP-β-CD) Janssen Biotech N.V. 
Methanol  Rathburn 
Nitecapone glucuronide Division of Pharmaceutical Chemistry* 
4-Nitrocatechol 1-O-glucuronide (1-O-NCG) Division of Pharmaceutical Chemistry* 
4-Nitrocatechol 2-O-glucuronide (2-O-NCG) Division of Pharmaceutical Chemistry* 
p-Nitrophenyl glucuronide  Sigma 
Perchloric acid  Merck 
Sodium hydroxide Eka Nobel 
Tolcapone glucuronide (TG) Division of Pharmaceutical Chemistry’ 
Toluene  Sigma-Aldrich 
*Luukkanen et. al 1999. 
 
Several biological matrices were obtained for study. Blank drug-free human urine (I,III,IV,V) 
was collected from healthy volunteers of both sexes. Authentic patient urine samples were 
obtained from a clinical patient study (IV). Blank human plasma (V) was from a blood bank 
(SPR, Helsinki, Finland). Blank rat plasma (V) was from male Han/Wistar rats (National 
Laboratory Animal Centre of the University of Kuopio, Finland). Other plasma samples were 
obtained from these rats after treatment with entacapone or with entacapone and HP-β-CD. Rat 
hepatocytes (II) were from adult male Sprague-Dawley rats (CNRS-University Henri Poincare 
Nancy, Faculty of Medicine, Vandoeuvre Nancy, France). Rat urine (II) was collected from 
male Wistar rats treated with apomorphine, dobutamine or entacapone (Helsinki University 
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Breeding Centre, Helsinki, Finland). Pooled human liver microsomes (II) were obtained from 
Human Biologics, Scottsdale, AZ, USA. 
 
4.2. Instrumentation 
 
The two hyphenated techniques, LC−MS (II, III, V) and CE−MS (IV), were carried out on 
different instruments. In the study of mass spectrometric and tandem mass spectrometric 
behaviour of glucuronides (I), the samples were introduced by direct infusion. The 
instrumentation and conditions for the studies are summarised in Table 3. 
 
Table 3. Instrumentation and conditions employed in development of methods for different drug 
conjugates. 
Paper LC or CE Column Eluent Mass 
spectrometer 
Ionisation 
I LKB 2150  
(LKB-produkter 
AB, Sweden) 
 
 0.1% acetic acid 
0.1% ammonium acetate 
Sciex API 300  
(Sciex, Concord, 
Canada) 
APCI 
(pos/neg) 
ESI 
(pos/neg) 
II HP 1100 
(Hewlett Packard, 
Waldbronn, 
Germany) 
Luna C18  
(150 x 1 mm, 5µm) 
Phenomenex, 
Torrance, CA, USA 
 
Waters Symmetry 
C18 (2.1 x 150 mm, 
5µm) 
Waters, Milford, MA, 
USA 
 
A: 0.1% FA  
B: 0.1% FA in 80% ACN 
 
Binary gradient: 
B 7.5% → 50% (45 min.),  
B 50% → 100% (1 min.) 
Sciex API 3000 
(Sciex, Concord, 
Canada) 
 
Esquire-LC Ion 
Trap LC/MS(n) 
system 
(Bruker Daltonics 
GmbH, Bremen, 
Germany). 
APCI 
(pos) 
APPI 
(pos) 
ESI (pos) 
III HP 1090 
(Hewlett Packard, 
Waldbronn, 
Germany) 
 
 
Waters Symmetry 
C18 (3.9 x 150 mm, 
5µm) 
Waters, Milford, MA, 
USA 
10 mM ammonium 
acetate (pH 7.0), 
acetonitrile 
(80:20a, 85:15b, 90:10c) 
Quattro II 
(Micromass, 
Altrincham, UK) 
ESI (neg) 
IV Beckman P/ACE 
System 2200 
(Beckman 
Instruments Inc., 
Palo Alto, CA, 
USA) 
Fused-silica  
(50 µm I.D. x 186 µm 
O.D., 85 cm) 
Polymicro 
Technologies Inc., 
Phoenix, AZ, USA 
 
20 mM ammonium 
acetate at ambient pH 
(6.84) 
Sciex API 300  
(Sciex, Concord, 
Canada) 
ESI (neg) 
V HP 1100 
(Hewlett Packard, 
Waldbronn, 
Germany) 
 
Waters 510 
(Waters, Milford, 
CA, USA) 
LiChrospher RP-18 
ADS  
(25x4 mm, 25 µm) 
Merck, Darmstadt, 
Germany 
 
Waters Symmetry 
C18 (3.9 x 150 mm, 
5µm) 
Waters, Milford, MA, 
USA 
20 mM ammonium 
acetate (pH 7.0), 
acetonitrile 
85:15, v/v 
Sciex API 300  
(Sciex, Concord, 
Canada) 
ESI (neg) 
ACN=acetonitrile, FA=formic acid 
a
 for TG, b for EEG and EZG, c for NG, 1- and 2-O-NKG 
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4.3. Mass spectrometric and tandem mass spectrometric behaviour of 
nitrocatechol glucuronides (I) 
 
Six standard compounds synthesised in the laboratory (Luukkanen et al. 1999) were used to 
clarify the mass spectrometric and tandem mass spectrometric behaviour of nitrocatechol-type 
glucuronides. Optimal MS and MS/MS conditions for each compound were determined in both 
positive and negative ion mode with APCI and ESI ionisation. The most important parameters 
optimised were declustering potential (orifice voltage), collision energy and, in APCI, also 
vaporiser temperature. 
 
4.4. Qualitative determination of drug conjugates in biomatrices (II) 
 
A screening method utilising LC−MS was developed for conjugates of catechols apomorphine, 
dobutamine and entacapone. The suitability of different ionisation methods−APCI, APPI and 
ESI−for the analysis was evaluated. The conjugates were analysed in different biomatrices: rat 
hepatocyte incubation mixture, rat urine and human microsome incubation mixture. Identities of 
the found conjugates (glucuronides, sulphates and methyl conjugates) were confirmed by 
MS/MS. 
 
4.5. Quantitation of nitrocatechol-type glucuronides in urine (III) 
 
A direct and fast LC−ESI-MS/MS method was developed for the quantitation of several 
nitrocatechol-type glucuronides in urine. Negative ion mode ionisation was used because the 
analytes were acidic. Ammonium acetate solution at pH 7 was chosen to ensure that the 
ionisation occurred in liquid phase; the ionic strength of the solution was optimised between 2 
and 20 mM. Urine samples were purified before analysis by solid-phase extraction. 
 
4.6. CE−ESI-MS/MS assay for E- and Z-entacapone and tolcapone 
glucuronides in urine (IV) 
 
The on-line coupling of capillary electrophoresis with mass spectrometry was achieved with a 
laboratory-made coaxial sheath-flow interface. The CE and MS parameters were optimised 
separately before the coupling of the instruments. Separation of entacapone glucuronide isomers 
and tolcapone glucuronide was optimised by choosing appropriate ionic strength (10-50 mM) 
and pH (5-8) of the ammonium acetate used as electrolyte solution and by optimising the 
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applied voltage and injection volume. Sample stacking was used to enhance the sensitivity of 
the analysis. 
 
4.7. Column-switching LC−ESI-MS/MS assay for entacapone glucuronide 
in plasma (V) 
 
Column-switching technique was utilised in the assay developed for direct analysis of 
entacapone glucuronide in rat plasma. A precolumn of restricted access media (RAM), allowed 
direct injection of plasma after the centrifugation step. The analysis proceeded as follows: 100 
µl of plasma was injected to the RAM column (25 × 4 mm, 25 µm), in which the analytes were 
retained, while proteins and other matrix components were eluted to waste. After sufficient 
washing time, the valve was switched, and with a change in eluent composition, the analytes 
were eluted in backflush mode to the analytical column for separation. During the separation 
step the precolumn was washed and equilibrated for the next sample. 
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5. Results and discussion 
 
The main results obtained in this work are shortly described in this section. More detailed 
information about the experimental conditions, analytical procedures and obtained results can be 
found in original papers I-V. Structures of the studied compounds are presented in Figure 5. 
 
5.1. Mass spectrometric behaviour of glucuronide conjugates 
 
Mass spectrometric and tandem mass spectrometric behaviour of six nitrocatechol-type 
glucuronides (structures I-VI in Fig. 5) ionised with ESI and APCI was discussed in detail in 
paper I. In the literature positive ion ionisation is more common than negative ion mode for 
glucuronide analysis, even though the glucuronide moiety has a carboxylic acid that is easily 
ionised in negative ion mode. This preference probably reflects the fact that many drugs that are 
metabolised via glucuronidation are basic in character and thus easily protonated and analysed 
in positive ion mode.  
Fig. 5. Structures of the catecholic compounds studied. 
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5.1.1. ESI-MS spectra 
 
Several mass spectrometric parameters have to be optimised in order to obtain the highest 
possible abundance of the analytes in MS. With ESI most of the ions are already formed in the 
liquid phase and thus the eluent composition has a significant role in the ionisation process. 
Optimisation of the eluent composition is discussed below (sect. 5.4). The first parameters to be 
optimised in ESI are those having an effect on the spray formation: the voltage of the capillary, 
which affects the intensity of the protonated molecules (Zhou and Cook 2000), and the velocity 
of the nebulising gas. The most important parameter, however, is the declustering potential (DP, 
i.e. orifice voltage or cone voltage), which determines the amount of in-source fragmentation. 
Glucuronides fragment readily and thus a careful optimisation of DP is necessary. Optimal DPs 
for the studied glucuronides were 10 and 30 eV in positive and negative ion mode, respectively, 
indicating a higher stability of the deprotonated molecules. At higher energies the compounds 
fragmented to a deprotonated or protonated aglycone decreasing the absolute intensity of the 
parent ion (paper I).  
 
Negative ion ESI-MS 
 
The negative ion ESI-MS spectra are presented in Table 2 of paper I. The main peak in all 
spectra was a deprotonated glucuronide [M-H]-. The other ions were small sodium adducts and 
the ions corresponding to deprotonated aglycone formed by the cleavage of the glycoside bond 
and the retention of negatively charged oxygen in the drug moiety. The glucuronides that were 
studied contain two acidic groups, carboxylic acid with pKa 3.2 (Perel et al. 1964) in the 
glucuronide part and less acidic phenolic hydroxyl group in the aglycone part. The pKa values 
of the phenolic hydroxyl groups in E-entacapone glucuronide (EEG) and Z-entacapone 
glucuronide (EZG) are 4.1 and 4.2, respectively (Wikberg et al. 1993). Probably, then, the 
primary site of deprotonation in the solvent employed (0.1% aqueous ammonium 
acetate/acetonitrile, 1:1, v/v) is the more acidic carboxylic acid moiety.  
 
Positive ion ESI-MS 
 
The positive ion ESI-MS spectra are presented in Table 3 in paper I. The main peak in the 
spectra was a protonated glucuronide [M+H]+. The spectra also showed the fragment ion [M+H-
glu]+ formed as a result of protonation of the aglycone moiety, followed by a transfer of 
hydrogen from the glucuronide part to the aglycone part and cleavage of the glycoside bond 
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with retention of oxygen in the aglycone moiety. The site of protonation cannot be determined 
with certainty since none of the compounds includes a basic group. The ionisation efficiency in 
positive ion mode is high for compounds having a nitrile or an amine group in their structure 
(EEG and EZG), suggesting that these groups are the site of protonation. From the weaker 
ionisation efficiency, the site of glucuronidation in compounds containing carbonyl group 
instead, (tolcapone glucuronide, TG and nitecapone glucuronide, NG) appears to be the 
carbonyl group. The failure of 4-nitrocatechol glucuronides to be ionised in positive ion mode is 
consistent with the above suggestions.  
 
5.1.2. APCI-MS spectra 
 
Formation of spray in a heated nebulizer interface is assisted by the heat and thus the 
temperature of the vaporiser needs to be optimised. The optimal temperature is dependent on the 
eluent composition, eluent flow rate and the analytes. Because they are thermolabile 
compounds, glucuronides are fragmented by the thermal energy of the heated nebulizer 
interface (Chui et al. 1994, Boguz et al. 1997a). As earlier, so in this study, the temperature was 
found to have an effect on the abundance of EZG (Figure 6). The abundance of EZG increased 
with the temperature up to 450°C, after which temperature the abundance decreased due to 
increased fragmentation. Neither the current nor the position of the corona discharge needle had 
much influence on the ionisation efficiency of the compounds. 
 
 
Fig. 6. Effect of temperature on the abundance of Z-entacapone glucuronide (precursor ion) and 
the fragment ion formed by loss of the glucuronide moiety. 
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Similarly to the ESI spectra, the main peaks in the negative ion APCI spectra were the ions [M-
H]- and [M-H-glu]- (I, Table 4). The influence of thermal energy was evident as a significantly 
more abundant deprotonated aglycone moiety than in the respective ESI spectra. In positive ion 
mode all APCI spectra exhibited an abundant protonated glucuronide ion, which was also the 
only ion in the spectra of TG and NG (I, Table 5). The positive ion mode spectra of EEG and 
EZG also showed an ion at m/z 306, corresponding to the loss of the glucuronide group and a 
proton transfer from the glucuronide group to the aglycone part. The ion at m/z 347 was 
confirmed by MS/MS experiments to have formed through loss of the 135 u [C4H7O5] species 
from the glucuronide moiety. This ion was not detected in positive ESI-MS spectra and thus a 
different site of protonation in APCI than in ESI is suggested. Owing to the low proton 
affinities, glucuronides of 4-nitrocatechol were not ionised under the positive APCI conditions. 
In contrast to the ESI spectra, no sodium adducts were found in APCI. 
 
5.2. Tandem mass spectrometry of glucuronide conjugates 
 
Tandem mass spectrometry of the studied compounds, in both positive and negative ion mode, 
gave unusual results: only one product ion, formed by the loss of the glucuronide moiety, was 
detected at low collision energies (below 30 eV) (paper I). The lack specific fragment ions is 
disadvantageous for structural characterisation. However, it is highly beneficial for quantitation, 
owing to the improved sensitivity. 
 
Dissociation of the glucuronides in MS/MS was studied with collision energies between 5 and 
40 eV in laboratory frame (ELAB). In negative ion mode, 30 eV produced the maximum 
abundance of deprotonated aglycone ions for EEG, EZG, TG and NG. 4-Nitrocatechols 
dissociated at somewhat lower collision energies (I, Figure 2). In positive ion mode the 
maximum absolute abundance of product ion was obtained at slightly different energies for each 
compound (I, Figure 3). The ESI-MS/MS spectra recorded in negative and positive ion mode 
are presented in Table 6, paper I.  
 
Fragmentation of the compounds was also studied with the same centre-of-mass collision 
energy (ECM). ECM was calculated with the following equation: (ECM = ELABmg/(mp + mg)) in 
which mg is mass of the target gas and mp is the mass of the parent ion (Dawson and Douglas 
1993). ECM was calculated to be 0.7 and 1.3 eV in positive and negative ion mode, respectively. 
These experiments showed fragmentation to increase with decreasing molecular weight. This is 
because the smaller the molecule is the fewer degrees of freedom exist. 
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The cis−trans-isomers of entacapone glucuronide gave rise to similar MS/MS spectra, while the 
positional isomers of 4-nitrocatechol glucuronides required different amounts of energy for 
fragmentation. It follows that EEG and EZG cannot be distinguished simply by MS or MS/MS, 
but 4-nitrocatechols can. 
 
Sodium adducts detected in positive ion mode ESI were more stable than the respective 
glucuronides under similar MS/MS conditions (I, Table 8). Sodium was concluded to be tightly 
attached to the aglycone part of the conjugate since the collisionally activated dissociation 
resulted in protonated sodium adducts of the aglycone moieties. In the case of TG, a fragment 
corresponding to the glucuronide moiety with sodium attached was detected, showing that the 
sodium can also be attached to the glucuronide part. 
 
APCI-MS/MS spectra in negative ion mode were similar to those recorded in ESI indicating 
similar internal energies of the compounds before the collision. As in positive ion APCI-MS 
spectra, an additional ion formed by the loss of 135 amu was observed in the positive ion APCI -
MS/MS spectra of EEG, EZG and TG. 
 
5.3. Evaluation of ionisation methods for the analysis of drug conjugates 
 
The suitability of different ionisation methods for the analysis of drug conjugates was studied in 
detail in paper II. In addition to the ESI and APCI methods discussed above, the applicability of 
a third method, APPI, was evaluated in conjugate analysis for the very first time. Analysis were 
made in positive ion mode. The compounds investigated were glucuronide, sulphate and methyl 
conjugates and mixed conjugates in which two groups are attached, generated in in vivo and in 
vitro incubations of drugs of catechol-structure−apomorphine, dobutamine, and entacapone.  
 
The number of conjugates was greatest with ESI (22). Methylated products, glucuronides and 
sulphates were all detected as their protonated molecules with good sensitivity, even though 
glucuronide and sulphate conjugates of apomorphine and dobutamine are ampholytes and 
entacapone glucuronide is an acid in water. In the case of apomorphine and dobutamine, the 
negative charge of the carboxylic acid appears to be neutralised, while the amino group retains a 
proton during the ionisation process. This can occur because the pH of the system is 
significantly increased due to the oxidation reactions of the eluent components at the tip of the 
sprayer. The difference in pH between the solution and a charged droplet may be as much as 
 37
four pH units (van Berkel et al. 1997). In the case of acidic entacapone glucuronide the negative 
charge is neutralised in the ESI process and protonation most likely takes place in the gas phase. 
Sulphate conjugates of entacapone were not detected. 
 
Ionisation in APCI is highly dependent on the proton affinities of the eluent and the analytes: 
ionisation occurs only if the PA of the analyte is higher than that of the eluent molecule. The 
proton transfer reaction was efficient for all compounds studied since the PAs of the amine or 
amide groups in their structures are higher than those of the eluent molecules. However, only 12 
conjugates were found with APCI than with ESI, probably because the sensitivity in APCI 
depends also on the volatility of the compounds. The sulphate and glucuronide conjugates of 
apomorphine and dobutamine were ionised in the acidic eluent owing to the strongly acidic 
character of the sulphates and the basic amine groups. The charged species are less volatile than 
the neutral ones and it follows that the conjugates mentioned are poorly vaporised in APCI. 
Entacapone, as noted earlier, has no basic group in its structure. Therefore, in acidic conditions, 
it is at least partly in neutral form and detected with reasonable sensitivity also with APCI.  
 
The ionisation mechanism in APPI has been explained above. The results obtained with APPI 
were similar to those obtained with APCI (II, Table 2). The poorer sensitivity with APPI than 
with ESI is probably mostly due, as in APCI, to the high vaporising temperatures of the charged 
glucuronide and sulphate conjugates and to the thermal degradation of the glucuronides. 
Nevertheless, the results obtained in this work, though promising, are only preliminary ones. 
The potential of APPI in drug conjugate analysis carried out with different eluents, dopants and 
temperatures must be thoroughly studied before conclusions are drawn about this new method. 
 
It is clear from the results that ESI is the method of choice for the present conjugates. When ESI 
was used, not only was the number of detected conjugates the greatest but also intensities were 
higher than when APCI or APPI was used. This indicates a better ionisation efficiency in ESI 
than in APCI or APPI. The aglycones and methyl conjugates were succesfully ionised with all 
ionisation methods. Glucuronide conjugates were ionised most efficiently in ESI, though they 
were also detected with APCI and APPI. Sulphate conjugates were detected only with ESI. No 
additional metabolites or information on the compounds was obtained with APCI or APPI 
relative to ESI.  
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5.4. Optimisation of the separation 
 
Separation of the analytes from matrix compounds, from each other, and from the internal 
standard is beneficial, or even necessary as in the case of isomers, even though a mass 
spectrometer is used for the detection. In this work, liquid chromatography (II,III,V) and 
capillary electrophoresis (IV) were evaluated for the separation. ESI was chosen as the method of 
ionisation for the reasons given above. Negative ion mode MS was preferred for detection when 
only glucuronides were analysed since good ionisation efficiency, owing to the acidic character of 
the glucuronides, was easily obtained in neutral pH (III-V).  
 
The development of an LC−MS method for the analysis of drug metabolites is sometimes quite 
difficult. The conditions required for a reasonable separation of the analytes and matrix 
compounds in LC may be unlike those needed for efficient ionisation and detection in MS. The 
best ionisation efficiency in ESI is normally achieved when the pH is adjusted to promote 
ionisation of the analyte above its neutral form, while the retention of the analyte with C 18 phase 
favours the neutral form. It follows that the conditions chosen for the identification of 
metabolites by LC−MS always involve compromise. In capillary electrophoresis, unlike in LC, 
ionised analytes are necessary. This is because the separation in CE is based on the 
electrophoretic mobilities of charged analytes; thus ESI is the ideal ionisation method for 
CE−MS. The problem in using CE and ESI together is the low flow rates required in CE 
compared with those needed for proper operation of the normal ESI source. Adding a suitable 
auxiliary eluent, a sheath liquid, to the flow via a T-piece, should solve this problem. 
 
Ammonium acetate was chosen as electrolyte for the LC−MS analysis of acidic glucuronides in 
urine samples (compounds I-VI in Fig. 5). A solution at pH 7 was found to ensure the ionisation 
and still give moderate retention of the analytes on the reversed phase column. Ionic strength of 
the electrolyte solution was optimised between 2 and 20 mM and the retention of the 
glucuronides was found slightly to increase with the concentration of ammonium acetate. Good 
separation and retention were obtained with the 10 mM electrolyte solution that was chosen for 
the analysis (III). Acetonitrile was preferred over methanol as organic solvent because lower 
backpressure and symmetrical peaks and better resolution were obtained with acetonitrile. 
 
Ammonium acetate and acetonitrile were also tested for the analysis of drug conjugates of 
apomorphine, dobutamine and entacapone (structures X, IX and III in Fig. 5) but found to be 
inappropriate (paper II). In this case, gradient elution was required to separate a wide range of 
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compounds with different acid-base properties. When ammonium acetate solution was used as a 
buffer, the baseline drifted and the stabilisation after the analysis took too long. Better results 
were obtained with an acidic eluent consisting of formic acid and acetonitrile. Because of the 
acidity of the eluent, positive ion mode was chosen for ionisation. 
 
Ammonium acetate was used as buffer species in the electrolyte solution for CE−MS to ensure 
the ionisation of the glucuronides. Optimisation of the ionic strength of the electrolyte solution 
is important since it has an effect on electroosmotic as well as on electrophoretic mobility. The 
ionic strength was optimised between 10 and 50 mM and the migration times of the studied 
glucuronides, EEG and EZG, were found to increase linearly with buffer concentration (IV, 
Table I). This is because the electro osmotic flow (EOF) from the anode towards the cathode 
decreased less than the electrophoretic mobility in opposite direction. Better resolution of the 
compounds was obtained at higher buffer concentrations, probably because of the diminished 
electrophoretic dispersion. The EOF and the dissociation state of the analyte, and thus the 
migration times, are dependent on pH. The influence of pH on the resolution of EEG and EZG 
was studied between pH 5 and 8. A pH of 6.84 (obtained for 20 mM electrolyte solution without 
adjustment) was chosen for the analysis as a compromise between the best possible resolution 
and shortest analysis time (IV, Table I). 
 
5.5. Comparison of LC−ESI-MS/MS and CE−ESI-MS/MS methods 
 
Three methods were developed for the quantitative analysis of nitrocatechol glucuronides in 
urine and plasma. A simple isocratic LC−ESI-MS/MS method was developed for the 
quantitation of EEG, EZG, TOG, NG and 4-nitrocatechol glucuronides in urine (III). The 
method is extremely rapid, allowing analysis of the compounds in just four minutes. After some 
modification of the eluent composition, it could probably be applied for other glucuronides, 
since the main fragment ion is the negatively charged drug moiety formed after the cleavage of 
the glucuronide part. The method is readily automated, and thus highly suitable for metabolic 
studies in which a large number of samples must be analysed. The only disadvantage of the 
method is the manual sample pre-treatment step, which increases the total analysis time, as well 
as the risk of sample loss and contamination.  
 
A similar LC−ESI-MS/MS was applied for the analysis of entacapone glucuronide in rat plasma 
(V). With this method the total analysis time of one sample was 22 minutes. However, the 
purification of the complex protein-containing samples was performed on-line with use of a 
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restricted access material (RAM) precolumn and column-switching technique. Thus the total 
time used for the analysis was less than for the method described for urine. With totally 
automated sample pre-treatment, the reliability and repeatability of the method are increased. 
Also the sensitivity is improved because the sample is concentrated in this procedure: up to 500 
µl of plasma can easily be injected to the RAM columns (Yu and Westerlund 1996a,b). The 
only manual step needed in the procedure is centrifugation and filtration of the samples. The 
method development is more complicated than for normal LC method development, however, 
because two different solvent compositions and column switching times must be optimised 
before it can be applied. The method can also be employed in the analysis of glucuronides in 
bile, urine and various in vitro incubation mixtures. For other matrices than plasma, the method 
is easily speeded up since a substantial part of the total time is used to wash the proteins of 
plasma to waste. 
 
The direct CE−ESI-MS and CE−ESI-MS/MS methods proved suitable for the quantitation of 
the glucuronide conjugates of entacapone and tolcapone in urine (IV). Analysis of the 
compounds takes 15 minutes. The rate limiting step is the required separation of the E- and Z-
entacapone glucuronides, which cannot be distinguished solely by MS. As is evident from the 
results, high plate numbers achieved in CE do not reflect the resolution between the compounds. 
Narrow peaks, however, together with low flow rates with no need for splitting, that usually is 
necessary in LC−ESI-MS, provide very low detection limits. Similarly to the fast LC−ESI-
MS/MS method (III), the samples were purified manually by solid-phase extraction, which 
increased the total analysis time. The development and optimisation of the CE−MS/MS method 
is a highly complicated and slow process demanding experienced personnel and much time. In 
routine applications this would be a major disadvantage. The advantages and the disadvantages 
of the different quantitative methods developed during this work are summarised in Table 4. 
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Table 4. Comparison of the LC−ESI-MS/MS and CE−ESI-MS/MS methods developed for the 
analysis of glucuronides in biological matrices. 
 LC−ESI-MS/MS (III) LC-RAM−ESI-MS/MS (V) CE−ESI-MS/MS (IV) 
Analytes EEG, EZG, NG, TG, 1-
O-NKG, 2-O-NKG, AG 
 
EEG, EZG EEG, EZG, TG 
Sample matrix Urine 
 
Plasma Urine 
Separation 
eluent/electrolyte 
composition 
 
10 mM NH4OAc pH 7, 
10-20% ACN 
20 mM NH4OAc pH 7,  
15% ACN 
20 mM NH4OAc,  
pH 6.84 
Sample pre-
treatment 
 
Off-line SPE On-line purification Off-line SPE 
Analysis time 
 
4 min 
 
22 min 15 min 
Disadvantages - off line sample pre 
treatment 
 
- multiple parameters to 
be optimised 
 
- fairly complicated method 
development and 
optimisation 
- easily clogged 
- small injection volume 
 
Advantages - simple to use 
- fast 
- easily automated 
- automated sample 
clean-up 
- suitable for different 
matrices 
- relatively fast method 
- no eluent waste 
 
 
5.6. Validation of methods 
 
Validation of a method is essential when its suitability for quantitative routine analysis is being 
evaluated. There are many validation guidelines to choose from, each with numerous parameters 
to evaluate. The thoroughness of a validation procedure should be in reasonable proportion to 
the intended use of the method. Parameters routinely tested in this work were linearity, 
repeatability (in-day and between-day), specificity, and limits of detection or limits of 
quantitation (III-V). Also, the recovery of extraction (IV,V), matrix effects and cross talk were 
evaluated (V). The validation of the methods is summarised in Table 5. For reasons of 
consistency, only the results obtained with E-entacapone glucuronide are presented. 
 
Between-day repeatability of the CE−ESI-MS/MS and RAM-LC−ESI-MS/MS methods was 
evaluated by injecting the same sample on consequent days (6-7 days) and was found to be 
acceptable for biological samples (relative standard deviation of the peak area ratios, RSD, 
below 15%). In-day repeatability was better for the fast LC−ESI-MS/MS method (III) (RSD 
2.6%) than for the RAM-LC−ESI-MS/MS method (RSD 5.7%). The repeatability of the 
instrumental system, studied by successive injections of the same sample, was good in both 
LC−MS systems (RSD 1.3-1.5%), but it was easier to determine the analytes in urine by LC-
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ESI−MS/MS than the analytes in plasma by RAM-LC−ESI-MS/MS. The linearity of the 
methods was good in all cases. In an evaluation of concentration range between 1 and 150 
µg/ml, the linearity varied between 0.9966 and 0.9998. Somewhat surprisingly, the most 
sensitive method was CE−ESI-MS/MS, despite the small injection volume (34 nl). With this 
method the limit of quantitation (S/N=3) was about 7 ng/ml, which means that only 0.3 pg of 
the compound was introduced to the MS. The RAM-LC−ESI-MS/MS method was almost as 
sensitive: despite the complexity of the plasma matrix the limit of detection was 1 pg of analyte 
introduced to the MS.  
 
The sensitivity of the LC−MS methods would probably be improved if the splitting of the flow 
(1:100, v/v) could be avoided or at least minimised. This is possible by using columns of 
smaller diameter (e.g. 2.1 or 1 mm). In this work a capillary column (i.d. 300 µm) was tested for 
the purpose. Use of capillary column, however, lengthened the analysis time dramatically. 
Therefore, the approach was not studied further. The use of shorter columns in order to reduce 
the analysis time is probably not possible either since the separation of entacapone glucuronides 
was critical even with the column length used (15 cm).  
 
Table 5. Summary of the validation of the quantitative methods. 
 LC−ESI-MS/MS CE−ESI-MS CE−ESI-MS/MS RAM-LC−ESI-
MS/MS 
 EEG EZG EEG EZG EEG EZG EEG EZG 
Repeatability 
- between-day 
 
- 
 
- 
 
13.2 
 
15.0 
 
14.8 
 
11.3 
 
14.0 
 
7.7 
- in-a-day 2.56 2.57 - - - - 5.7 6.9 
- instrument 1.52 1.52 8.34 8.10 5.02 13.6 1.3 1.9 
Linearity (r2) 0.9994 0.9998 0.9966 0.9970 0.9990 0.9988 0.9984 0.9968 
 1 – 60 µg/ml 2 –150 µg/ml 0.05 – 1 µg/ml 2 – 100 µg/ml 
Limit of detection 5 pg to MS 3.4 pg to MS 0.3 pg to MS 1 pg to MS 
 
 
5.7. Sample pre-treatment 
 
Sample loss during pre-treatment was evaluated in papers IV and V. Urine samples analysed by 
the methods described in papers III and IV were purified by simple SPE method in acidic 
conditions. Acidified urine samples were loaded to SPE columns (C18), washed with dilute acid 
and then a small amount of water in order to remove the salts in urine, and finally, the 
glucuronides were eluted from the columns with methanol. The recovery of the extraction was 
exceeded 95% demonstrating the suitability of the procedure for urine samples (IV). On-line 
sample purification with RAM column was applied in the study of rat plasma samples (V). In 
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the case of plasma samples SPE was inappropriate and recovery (10-61%) was poorer than that 
obtained with the RAM procedure (78-101%). 
 
Although CE and LC have been used for the analysis of biological samples with no or minimal 
sample pre-treatment, it is usually necessary to remove the endogenous compounds before the 
analysis in order to avoid serious matrix effects. Undetected endogenous compounds, such as 
amines, in biomatrices can ruin the chromatography or suppress the ionisation in ESI 
(Matuszewski et al. 1998, Fu et al. 1998). A significant part of the validation procedure of the 
RAM-LC−ESI-MS/MS method was the evaluation of specificity and studies on cross talk and 
the matrix effect. Specificity was studied by comparing the ion chromatograms obtained in the 
analyses of a blank plasma sample, a plasma sample spiked with the studied analytes, and a 
standard solution of the analytes. No peaks were present in the ion chromatogram of the blank 
plasma. Specificity, and the absence of cross talk between the MS/MS channels, were further 
confirmed by injecting a high concentration of E-entacapone glucuronide to the system and 
monitoring the channel of the internal standard (TOG) near LOD values. No cross talk existed 
because there was no rise in the signal of the channel at the retention time of EEG. Likewise, 
when the internal standard was injected there was no response on the channel of the analytes 
(Figure 4 in paper V). A matrix effect would be seen as poor reproducibility and accuracy of the 
assay, because the coeluting undetected matrix components would reduce the ion intensity of 
the analytes and affect the absolute peak areas (Matuszewski et al. 1998). No matrix effect was 
detected in this work: the absolute peak areas of the analytes and those of the internal standard 
spiked in five different batches of rat plasma were highly reproducible (RSD 7.3% and 8.5%, 
respectively).  
 44
6. Conclusions 
 
Mass spectrometric and tandem mass spectrometric behaviour of six nitrocatechol-type 
glucuronides was studied using electrospray and atmospheric pressure chemical ionisation in 
both positive and negative ion mode. All the glucuronides were ionised in negative but not in 
positive ion mode and thus the negative ion mode is preferred for the analysis. The 
deprotonation site in negative ion mode is suggested to be the carboxylic acid group in the 
glucuronide moiety. Though the compounds have no basic groups in their structures, four of 
them were ionised in positive ion APCI as well as in positive ion ESI. It follows that, at least in 
part, the ionisation in ESI takes place via gas phase reactions. Collisionally activated 
dissociation of the compounds in both positive and negative ion mode showed the ion formed 
by the loss of the glucuronide moiety as the main product. This ion was the only product ion in 
the negative ion mode and was extremely abundant and stable owing to the resonance 
stabilisation. Highly sensitive and selective methods of analysis can be developed on the basis 
of this finding. ESI was found to be over ten times more sensitive than APCI and is preferred 
for ionisation of the studied glucuronides.  
 
ESI also proved to be the most suitable ionisation method when the applicability of ESI, APCI 
and APPI was evaluated for the screening of different drug conjugates in biological matrices 
with LC−MS. The highest number of conjugates was found when ESI was used. As well, the 
abundance of the detected compounds was noticeably higher with ESI than with APCI or APPI. 
Most probably this is because the drug conjugates, being thermolabile and of low volatility, 
were not efficiently vaporised and were, at least in part, decomposed to the corresponding 
aglycone. The suitability of APPI was studied only superficially, however. More careful 
optimisation of the parameters and numerous additional tests are required before the superiority 
of the other methods can be concluded. Tandem mass spectrometry was required for the 
confirmation of the conjugates. The primary cleavage in the case of glucuronide and sulphate 
conjugates was the loss of the conjugate group. It follows that the site of conjugation cannot be 
determined only with MS/MS. This might be possible in the case of methylation, however, 
owing to the more stable molecule and characteristic product ions. 
 
Two LC−ESI-MS/MS methods and a CE−ESI-MS/MS method were developed for direct 
quantitation of nitrocatechol-type glucuronides in biological matrices. The methods, which were 
based on single reaction monitoring, were shown to be linear, repeatable, selective and highly 
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sensitive. The methods, developed with the help of synthesised standard compounds, allowed 
reliable analysis of intact glucuronides in complex biomatrices. The urine samples analysed 
with CE− or LC−ESI-MS/MS were purified by off-line solid-phase extraction before the 
analysis, while the plasma samples analysed with LC−ESI-MS/MS were purified on-line with 
the use of special precolumn material and column-switching technique. The two LC−ESI-
MS/MS methods are relatively simple to apply and easily modified for the analysis of different 
glucuronides in different matrices and so are well suited for routine use. The method 
development in CE−ESI-MS/MS was more difficult and the maintenance of the instrumentation 
requires highly skilled personnel. Probably, then, CE−MS is the method of choice only for 
research purposes or where only limited amounts of sample are available. 
 
 46
7. Acknowledgements 
 
The present study was carried out in the Division of Pharmaceutical Chemistry, Department of 
Pharmacy, University of Helsinki, during the years 1996-2001. 
 
I am most grateful to my supervisor Prof. Risto Kostiainen for teaching me almost everything I 
know today about mass spectrometry and hyphenated techniques. Without his excellent 
quidance and never failing enthusiasm this work would have been much more difficult and 
time-consuming.  
 
I wish to express my gratitude to Prof. Jyrki Taskinen, the former head of the division, for 
providing the excellent facilities for my work. Very special thanks are due to Professor Emerita 
Seija Tammilehto, who suggested to me many years ago that even ordinary people like myself 
can do PhD studies. Still further thanks go to all my colleagues in the Division of 
Pharmaceutical Chemistry for providing a most pleasant working atmosphere. 
 
Knut Raanaa is deserving of mention for the excellent technical assistance provided during the 
course of his pro gradu studies. 
 
Docents Jorma Jalonen and Heli Sirén carried out a careful review of the manuscript and made 
valuable comments that led to its improvement. Dr. Kathleen Ahonen revised the language of 
the present manuscript and most of the articles. I am most grateful to them as well. 
 
Finally I extend my warmest thanks to my husband Jouni for his patience and support over the 
years. And especial thanks go to my children, Riku and Olli, who every now and then came to 
remind me that there are other important things in this world besides science. 
 
Financial support from the Pharmacy of the University of Helsinki, the Finnish Pharmaceutical 
Society and the Farmos Foundation is gratefully acknowledged. 
 47
8. References 
 
Ackermann, B.L., Gillespie, T.A., Regg, B.T., Austin, K.F. and Coutant, J.E., Application of packed 
liquid chromatography/mass spectrometry with electrospray ionization to the study of the human 
biotransformation of the anti-emetic drug dolasetron. J. Mass Spectrom. 31 (1996) 681. 
 
Altria, K.D., Optimization of sensitivity in capillary electrophoresis. LC-GC Int. Jan (1999) 24. 
 
Andreoli, R., Manini, P., Bergamaschi, E., Mutti, A., Franchini, I. and Niessen, W.M.A., Determination 
of naphtalenes in human urine by liquid chromatography−mass spectrometry with electrospray ionization. 
J. Chromatogr. A 847 (1999) 9. 
 
Baillie, T.A., Advances in the application of mass spectrometry to studies of drug metabolism, 
pharmacokinetics and toxicology. Int. J. Mass Spectrom. Ion Processes, 118/119 (1992) 289. 
 
Banks, J.F. Jr., Shen, S., Whitehouse, C.M. and Fenn, J.B., Ultrasonically assisted electrospray ionization 
for LC/MS determination of nucleosides from a transfer RNA digest. Anal. Chem. 66 (1994a) 406. 
 
Banks, J.F. Jr., Quinn, J.P. and Whitehouse, C.M., LC/ESI-MS determination of proteins using 
conventional liquid chromatography and ultrasonically assisted electrospray. Anal. Chem. 66 (1994b) 
3688. 
 
Bean, K. A. and Henion, J. D., Direct determination of anabolic steroid conjugates in human urine by 
combined high-performance liquid chromatography and tandem mass spectrometry. J. Chromatogr. B. 
690 (1997) 65. 
 
Bedford, C.T., Glucuronic acid conjugates. J. Chromatogr. B, 717 (1998) 313. 
 
van Berkel, G.J., Zhou, F. and Aronson, J.T., Changes in bulk solution pH caused by the inherent 
controlled-current electrolytic process of an electrospray ion source. Int. J. Mass Spectrom. Ion Processes 
162 (1997) 55. 
 
Blanchet, M., Bru, G., Guerret, M., Bromet-Petit, M. and Bromet, N., Routine determination of morphine, 
morphine 3-β-D-glucuronide and morphine 6-β-D-glucuronide in human serum by liquid 
chromatography coupled to electrospray mass spectrometry. J. Chromatogr. A 854 (1999) 93. 
 
Bogusz, M.J., Krüger, K.D., Maier, R-D., Erkwoh, R. and Tuchtenhagen, F., Monitoring of olanzapine in 
serum by liquid chromatography-atmospheric pressure chemical ionization mass spectrometry. J. 
Chromatogr. B 732 (1999a) 257. 
 
Bogusz, M.J., Maier, R-D. and Driessen, S., Morphine, morphine-3-glucuronide, morphine-6-
glucuronide, and 6-monoacetylmorphine determined by means of atmospheric pressure chemical 
ionization-mass spectrometry-liquid chromatography in body fluids of heroin victims. J. Anal. Toxicol. 
21 (1997a) 346. 
 
Bogusz, M.J., Maier, R-D., Erkens M. and Driessen, S., Determination of morphine and its 3- and 6-
glucuronides, codeine, codeine-glucuronide and 6-monoacetylmorphine in body fluids by liquid 
chromatography atmospheric pressure chemical ionization mass spectrometry. J. Chromatogr. B. 703 
(1997b) 115. 
 
Boone, C.M., Waterval, J.C.M., Lingeman, H., Ensing, K. and Underberg, W.J.M., Capillary 
electrophoresis as a versatile tool for the bioanalysis of drugs−a review. J. Pharm. Biomed. Anal. 20 
(1999) 831. 
 
Boos, K.-S. and Rudolphi, A., The use of restricted-access media in HPLC, part I – classification and 
review. LC⋅GC Int. 11 (1998a) 84. 
 
 48
Boos, K.-S. and Rudolphi, A., The use of restricted-access media in HPLC, part II – applications. LC⋅GC 
Int. 11 (1998b) 224. 
 
Boos, K.-S. and Schäfer, C., LiChrospher ADS application guide. Merck KgaA, Darmstad, 2000. 
 
Borts, D.J. and Bowers, L.D., Direct measurement of urinary testosterone and epitestosterone conjugates 
using high-performance liquid chromatography/tandem mass spectrometry. J. Mass Spectrom. 35 (2000) 
50. 
 
Bowers, L.D. and Sanaullah, Direct measurement of steroid sulfate and glucuronide conjugates with high-
performance liquid chromatography-mass spectrometry. J. Chromatogr. B 687 (1996) 61-68. 
 
Brady, T.C., Kind, A.J., Hyde, W.H., Favrow, M. and Hill, D.W., Isolation, purification, and structural 
characterization of flunixin glucuronide on greyhound dogs. Drug Metab. Dispos. 26 (1998) 294. 
 
von Brocke, A., Nicholson, G. and Bayer, E., Recent advances in capillary electrophoresis/electrospray-
mass spectrometry. Electrophoresis 22 (2001) 1251. 
 
Brownsill, R., Combal, J.-P., Taylor, A., Bertrand, M., Luijten, W. and Walther, B., The application of 
electrospray and neutral-loss mass spectrometry to the identification of the metabolites of S12813 in rat 
liver slices. Rapid Commun. Mass Spectrom. 8 (1994) 361. 
 
Bruins, A.P., Negative ion desorption chemical ionization mass spectrometry of some underivatized 
glucuronides. Biomed. Mass Spectrom. 8 (1981) 31. 
 
Bruins, A.P., Mechanistic aspects of electrospray ionization. J. Chromatogr. A 794 (1998) 345. 
 
Bruins, A.P., Covey, T.R. and Henion, J.D., Ion spray interface for combined liquid 
chromatography/atmospheric pressure ionization mass spectrometry. Anal. Chem. 59 (1987) 2642. 
 
Cai, J. and El Rassi, Z., On-line preconcentration of triazine herbicides with tandem octadecyl capillaries-
capillary zone electrophoresis. J. Liq. Chromatogr. 15 (1992) 1179. 
 
Carroll, D.I., Dzidic, I., Stillwell, R.N., Haegele, K.D. and Horning, E.C., Atmospheric pressure 
ionization mass spectrometry: corona discharge ion source for use in liquid chromatograph−mass 
spectrometer−computer analytical system. Anal. Chem. 47 (1975) 2369. 
 
Chui, Y. C., Esaw, B. and Laviolette, B., Investigation of the metabolism of azaperone in horse. J. 
Chromatogr. B, 652 (1994) 23. 
 
Chung, B.-C., Mallamo, J.P., Juniewicz, P.E. and Shackleton, C.H.L., Synthesis of deuterium-labeled 5α-
androstane-3α,17β-diol and its 17β-glucuronide. Steroids 57 (1992) 530. 
 
Clarke, D.J. and Burchell, B., The uridine diphosphate glucuronosyltransferase multigene family: 
Function and regulation, in Conjugation-deconjugation reactions in drug metabolism and toxicity, 
Kauffman, F. C. (Ed.), Springer-Verlag, Berlin-Heidelberg (1994) 3-43. 
 
Clarke, N.J., Rindgen, D., Korfmacher, W.A. and Cox, C.A., Systematic LC/MS metabolite identification 
in drug discovery. Anal. Chem. 73 (2001) 430A-439A. 
 
Clayton, E., Taylor, S., Wright, B. and Wilson, I.D., The application of high performance liquid 
chromatography, coupled to nuclear magnetic resonance spectroscopy and mass spectrometry (HPLC-
NMR-MS), to the characterisation of ibuprofen metabolites from human urine. Chromatographia 47 
(1998) 264. 
 
Coldham, N.G., Biancotto, G., Montesissa, C., Howells, L.C. and Sauer, M.J., Utility of isolated 
hepatocytes and radio-HPLC-MSn for the analysis of the metabolic fate of 19-nortestosterone laurate in 
cattle. Analyst 123 (1998) 2589. 
 49
 
Creveling, C.R. and Thakker, D.R., O-, N-, and S-Methyltransferases, in Conjugation-deconjugation 
reactions in drug metabolism and toxicity, Kauffman, F. C. (Ed.), Springer-Verlag, Berlin-Heidelberg 
(1994) 189-216. 
 
Dawson, P.H. and Douglas, D.J. Collisionally activated dissociation of low kinetic energy ions, in 
Interpretation of mass spectra, Mclafferty, F.W., (Ed.), University Science Books, Mill Valley 
(California), (1993) 125-147. 
 
Dear, G.J., Harrelson, J.C., Jones, A.E., Johnson, T.E. and Pleasance, S., Identification of urinary and 
biliary conjugated metabolites of the neuromuscular blocker 51W89 by liquid chromatography/mass 
spectrometry. Rapid Commun. Mass Spectrom. 9 (1995) 1457. 
 
Dienes-Nagy, A., Rivier, L., Giroud, C., Augsburger, M. and Mangin, P., Method for quantification of 
morphine and its 3- and 6-glucuronides, codeine, codeine glucuronide and 6-monoacetylmorphine in 
human blood by liquid chromatography−electrospray mass spectrometry for routine analysis in forensic 
toxicology. J. Chromatogr. A 854 (1999) 109. 
 
Ding, J. and Vouros, P., Advances in CE/MS, recent developments in interfaces and applications. Anal. 
Chem. News&Features June 1 (1999) 378A. 
 
Doerge, D.R., Chang, H.C., Churchwell, M.I. and Holder, C.L., Analysis of soy isoflavone conjugation in 
vitro and in human blood using liquid chromatography-mass spectrometry. Drug Metab. Dispos. 28 
(2000) 298. 
 
Dole, M., Mack, L.L., Hines, R.L., Mobley, R. C., Ferguson, L.D. and Alice, M.B., Molecular beams of 
macroions. J. Chem. Phys. 49 (1968) 2240. 
 
Ehlhardt, W.J., Woodland, J.M., Baughman, T.M., Vandenbranden, M., Wrighton, S.A., Kroin, J.S., 
Norman, B.H. and Maple, S., Liquid chromatograohy/nuclear magnetic resonance spectroscopy and 
liquid chromatography/mass spectrometry identification of novel metabolites of the multidrug resistance 
modulator LY335979 in rat bile and human liver microsomal incubations. Drug Metab. Dispos. 26 (1998) 
42. 
 
Favetta, P., Dufresne, C., Désage, M., Païssé, O., Perdrix, J.P., Boulieu, R. and Guitton, J., Detection of 
new propofol metabolites in human urine using gas chromatography/mass spectrometry and liquid 
chromatography/mass spectrometry techniques. Rappid Commun. Mass Spectrom. 14 (2000) 1932. 
 
Favetta, P., Guitton, J., Degoute, C.S., Van Daele, L. and Boulieu, R., High-performance liquid 
chromatographic assay to detect hydroxylate and conjugate metabolites of propofol in human urine. J. 
Chromatogr. B 742 (2000) 25. 
 
Fenselau, C., Liberato, D. J., Yergey, J. A., Cotter, R. J. and Yergey, A. L., Comparison of thermospray 
and fast atom bombardment mass spectrometry as solution-dependent ionization techniques. Anal. Chem. 
56 (1984) 2759-2762. 
 
Fu, I., Woolf, E.J. and Matuszewski, B.K., Effect on the sample matrix on the determination of indanavir 
in human urine by HPLC with turbo ion spray tandem mass spectrometric detection. J. Pharm. Biomed. 
Anal. 18 (1998) 347. 
 
Gibson, G.C. and Skett, P., Introduction to drug metabolism, Gibson, G.C. and Skett, P. (Edts.) Blackie 
Academic and Professional, London (1994), 1-34. 
 
Gilar, M., Bouvier, E.S.P. and Compton, B.J., Advances in sample preparation in electromigration, 
chromatographic and mass spectrometric methods. J. Chromatogr. A 909 (2001) 111. 
 
Gu, J., Zhong, D. and Chen, X., Analysis of O-glucuronide conjugates in urine by electrospray ion trap 
mass spectrometry. Fresenius Anal. Chem. 365 (1999) 553. 
 50
 
Hankin, J.A., Wheelan, P. and Murphy, R.C., Identification of novel metabolites of prostaglandin E2 
formed by isolated rat hepatocytes. Arch. Biochem. and Biophys. 340 (1997) 317. 
 
Harrison, A.G., Chemical ionization mass spectrometry. CRC Press, Inc., Boca Raton, Florida (1982) 15. 
 
He, H., McKay, G. and Midha, K.K., Phase I and II metabolites of benztropine in rat urine and bile. 
Xenobiotica 25 (1995) 857. 
 
Heitmeier, S. and Blaschke, G., Direct determination of paracetamol and its metabolites in urine and 
serum by capillary electrophoresis with ultraviolet and mass spectrometric detection. J. Chromatogr. B, 
721 (1999) 93. 
 
Hennion, M-C., Solid-phase extraction: method development, sorbents, and coupling with liquid 
chromatography. J. Chromatogr. A 856 (1999) 3. 
 
Higashi, T., Horike, M., Kikuchi, R. and Shimada, K., In vitro and in vivo glucuronidation of 24,25-
dihydroxyvitamin D3. Steroids 64 (1999) 715. 
 
Higashi, T., Miura, K., Kikuchi, R., Shimada, K., Hiyamizu, H., Ooi, H., Iwabuchi, Y., Hatakeyama, S. 
and Kubodera, N., Characterization of new conjugated metabolites in bile of rats administered 24,25-
dihydroxyvitamin D3 and 25-hydroxyvitamin D3. Steroids 65 (2000) 281. 
 
Hiraoka, K., Fukasawa, H., Matsushita, F. and Aizawa K., High-flow liquid chromatography/mass 
spectrometry interface using a parallel ion spray. Rapid Commun. Mass Spectrom. 9 (1995) 1349. 
 
Hjertén, S., Free zone electrophoresis. Chromatogr. Rev. 9 (1967) 122. 
 
Hofmann, U., Pecia, M., Heinkele, G., Dilger, K., Kroemer, H.K. and Eichelbaum, M., Determination of 
propafenone and its phase I and phase II metabolites in plasma and urine by high-performance liquid 
chromatography-electrospray ionization mass spectrometry. J. Chromatogr. B 748 (2000) 113. 
 
Hopfgartner, G., Bean, K., Henion, J.D. and Henry, R.A., Ion spray mass spectrometric detection for 
liquid chromatography: a concentration or a mass-flow-sensitive device? J. Chromatogr. 647 (1993) 51. 
 
Horning, E.C., Carroll, D.I., Dzidic, I., Haegele, K.D., Horning, M.G. and Stillwell, R.N., Atmospheric 
pressure ionization (API) mass spectrometry. Solvent-mediated ionization of samples introduced in 
solution and in liquid chromatograph effluent stream. J. Chrom. Sci. 12 (1974) 725. 
 
Horning, E.C., Horning, M.G., Carroll, D.I., Dzidic, I., Haegele, K.D. and Stillwell, R.N., New picogram 
detection system based on a mass spectrometer with an external ionization source at atmospheric 
pressure. Anal. Chem. 45 (1973) 936. 
 
Ikegawa, S., Murao, N., Oohashi, J. and Goto, J., Separatory determination of diastereomeric ibuprofen 
glucuronides in human urine by liquid chromatography/electrospray ionization-mass spectrometry. 
Biomed. Chrom. 12 (1998) 317. 
 
Ikonomou, M.G. and Kebarle, P., A heated electrospray source in mass spectrometry for analytes from 
aqueous solutions.  J. Am. Soc. Mass Spectrom. 5 (1994) 791. 
 
Iribarne, J.V. and Thomson, B.A., On the evaporation of small ions from charged droplets. J. Chem. 
Phys. 64 (1976) 2287. 
 
Jia, Q., Hong, M-F., Pan, Z-X. and Orndorff, S., Quantification of urine 17-ketosteroid sulfates and 
glucuronides by high-performance liquid chromatography−ion trap mass spectroscopy. J. Chromatogr. B 
750 (2001) 81. 
 
 51
Jörgenson, J.W. and Lukacs, K.D., Zone electrophoresis in open-tubular glass capillaries. Anal. Chem. 53 
(1981) 1298. 
 
Kassahun, K., Mattiuz, E., Nyhart, E. Jr., Obermeyer, B., Gillespie, T., Murphy, A., Goodwin, R.M., 
Tupper, D., Callaghan, J.T. and Lemberger, L., Disposition and biotransformation of the antipsychotic 
agent olanzapine in humans. Drug Metab. Dispos. 25 (1997) 81. 
 
Kauffman, F.C., Zaleski, J., Thurman, R.G. and Kwei, G.Y., Biologically active conjugates of drugs and 
toxic chemicals, in Conjugation-deconjugation reactions in drug metabolism and toxicity, Kauffman, F. 
C. (Ed.), Springer-Verlag, Berlin-Heidelberg (1994) 341-366. 
 
Kauppila, T., Kuuranne, T., Kotiaho, T. and Kostiainen, R., Effect of solvent on the ionisation of 
naphthalenes by atmospheric pressure photo ionisation mass spectrometry (APPI-MS). Proceedings of the 
49th ASMS conference on mass spectrometry and allied topics, Chicago, Illinois, 2001. 
 
Kebarle, P. and Tang, L., From ions in solution to ions in gas phase. The mechanism of electrospray mass 
spectrometry. Anal. Chem. 65 (1993) 3654. 
 
Khan, S., Teitz, D.S. and Jemal, M., Kinetic analysis by HPLC-electrospray mass spectrometry of the pH-
dependent acyl migration and solvolysis as the decomposition pathways of ifetroban 1-O-acyl 
glucuronide. Anal. Chem. 70 (1998) 1622. 
 
Kojima, J., Fujino, H., Abe, H., Yosimura, M., Kanda, H. and Kimata, H., Identification of metabolites of 
NK-104, an HMG-CoA reductase inhibitor, in rat, rabbit and dog bile. Biol. Pharm. Bull. 22 (1999) 142. 
 
Kondo, T., Yoshida, K., Yoshimura, Y., Motohashi, M. and Tanayama, S., Characterization of conjugated 
metabolites of a new angiotensin II receptor antagonist, candesartan cilexetil, in rats by liquid 
chromatography/electrospray tandem mass spectrometry following chemical derivatization. J. Mass 
Spectrom., 31 (1996) 873. 
 
Koster, G. and Bruins, A.P, Mechanism for ion formation in LC/MS by atmospheric pressure photo-
ionization (APPI), Proceedings of the 49th ASMS conference on mass spectrometry and allied topics, 
Chicago, Illinois, 2001. 
 
Kostiainen, R. and Bruins, A., Effect of multiple sprayers on dynamic range and flow rate limitations in 
electrospray and ionspray mass spectrometry. Rapid Commun. Mass Spectrom. 8 (1994) 549. 
 
Kuhr, W.G., Capillary electrophoresis. Anal. Chem. 62 (1990) 403R 
 
Kuuranne, T., Vahermo, M., Leinonen, A. and Kostiainen, R., Electrospray and atmospheric pressure 
chemical ionization tandem mass spectrometric behavior of eight anabolic steroid glucuronides. J. Am. 
Soc. Mass Spectrom. 11 (2000) 722. 
 
Lausecker, B., Hopfgartner, G. and Hesse, M., Capillary electrophoresis−mass spectrometry coupling 
versus micro-high-performance liquid chromatography−mass spectrometry coupling: a case study. J. 
Chromatogr. B, 718 (1998) 1. 
 
Lee, E.D. and Henion, J.D., Thermally assisted electrospray interface for liquid chromatography/mass 
spectrometry. Rapid Commun. Mass Spectrom. 6 (1992) 727. 
 
Lee, E.D., Mück, W., Henion, J.D. and Covey, T.R., Liquid junction coupling for capillary zone 
electrophoresis/ion spray mass spectrometry. Biomed. Environ. Mass Spectrom. 18 (1989) 844. 
 
Li, C., Meng, X., Lee, M.J., Lu, H., Sheng, S., Buckley, B. and Yang, C.S., Analysis of urinary 
metabolites of tea catechins by liquid chromatography/electrospray ionisation mass spectrometry. Chem. 
Res. Toxicol. 14 (2001) 702. 
 
 52
Liberato, D.J., Fenselau, C.C., Vestal, M.L. and Yergey, A.L., Characterization of glucuronides with a 
thermospray liquid chromatography/mass spectrometry interface. Anal. Chem. 55 (1983) 1741. 
 
Low, L.K. and Castagnoli, N. Jr, Wilson and Giswold’s textbook of organic medicinal and 
pharmaceutical chemistry, 9. p., Delgado, J. N and Remers, W. A. (Edts.), J. B. Lippincott Company, 
Philadelphia, (1991) 416. 
 
Luo, H., McKay, G. and Midha, K.K., Identification of clozapine N+-glucuronide in the urine of patients 
treated with clozapine using electrospray mass spectrometry. Biol. Mass Spectrom. 23 (1994) 147. 
 
Luukkanen, L., Kilpeläinen, I., Kangas, H., Ottoila, P., Elovaara, E. and Taskinen, J., Enzyme-assisted 
synthesis and structural characterization of nitrocatechol glucuronides. Bioconj. Chem. 10 (1999) 150. 
 
Maggs, J.L., Pirmohamed, M., Kitteringham, N.R. and Park, B.K., Characterization of the metabolites of 
carbamazepine in patient urine by liquid chromatography/tandem mass spectrometry. Drug Metab. 
Dispos. 25 (1997) 275. 
 
Majors, R.E., Boos, K.-S., Grimm, C.-H., Lubda D. and Wieland G., Practical guidelines for HPLC-
integrated sample preparation using column switching. LC-GC 14 (1996) 554. 
 
Manini, P., Andreoli, R., Mutti, A., Bergamaschi, E. and Niessen, W.M.A., Determination of n-hexane 
metabolites by liquid chromatography/mass spectrometry 2. Glucuronide-conjugated metabolites in 
untreated urine samples by electrospray ionization. Rapid Commun. Mass Spectrom. 12 (1998a) 1615. 
 
Manini, P., Andreoli, R., Mutti, A., Bergamaschi, E., Franchini, I. and Niessen, W.M.A., Determination 
of glucuronides of molecules of toxicological interest by liquid chromatography negative-ion mass 
spectrometry with atmospheric pressure chemical ionization. Chromatographia 47 (1998b) 659. 
 
Matuszewski, B.K., Constanzer, M.L. and Chavez-Eng, C.M., Matrix effect in quantitative LC/MS/MS 
analyses of biological fluids: a method for determination of finasteride in human plasma at picogram per 
milliliter concentrations. Anal. Chem. 70 (1998) 882. 
 
McNeilly, P.J., Torchin, C.D., Anderson, L.W., Kapetanovic, I.M., Kupferberg, H. and Strong, J.M., In 
vitro glucuronidation of D-23129, a new anticonvulsant, by human liver microsomes and liver slices. 
Xenobiotica 27 (1997) 431. 
 
Meier, H. and Blaschke, G., Capillary electrophoresis-mass spectrometry, liquid-chromatography-mass 
spectrometry and nanoelectrospray-mass spectrometry of praziquantel metabolites. J. Chromatogr. B 748 
(2000) 221. 
 
Meisheri, K.D., Cipkus, L.A. and Taylor, C.J., Mechanism of action of minoxidil sulfate-induced 
vasodilatation: a role for increased K+ permeability. J. Pharmacol. Exp. Ther. 245 (1988) 751. 
 
Miners, J.O. and MacKenzie, P.I., Drug glucuronidation in humans. Pharmac. Ther. 51 (1991) 347. 
 
Moini, M., Design and performance of a universal sheathless capillary electrophoresis to mass 
spectrometry interface using a split-flow technique. Anal. Chem. 73 (2001) 3497. 
 
Mulder, G. J., Coughtrie, M.W.H. and Burchell, B., Glucuronidation, Mulder, G.J. (Ed.) Taylor & 
Francis, London (1990), 51-105. 
 
Mutlib, A.E., Chen, H., Nemeth, G., Gan, L.-S. and Christ, D.D., Liquid chromatography/mass 
spectrometry and high-field nuclear magnetic resonance characterization of novel mixed diconjugates of 
the non-nucleoside human immunodeficiency virus-1 reverse transcriptase inhibitor, efavirenz. Drug 
Metab. Dispos. 27 (1999) 1045. 
 
Naidong, W., Lee, J.W., Jiang, X., Wehling, M., Hulse, J.D. and Lin, P.P., Simultaneous assay of 
morphine, morphine-3-glucuronide and morphine-6-glucuronide in human plasma using normal-phase 
 53
liquid chromatography-tandem mass spectrometry with a silica column and an aqueous organic mobile 
phase. J. Chromatogr. B 735 (1999) 255. 
 
Niessen W.M.A., LC-MS in quantitative analysis. Rev. Anal. Chem. 19 (2000) 289. 
 
Niessen W.M.A. and Tinke, A.P., Liquid chromatography−mass spectrometry. General priciples and 
instrumentation. J. Chromatogr. A 703 (1995) 37. 
 
Nilsson S., Wetterhall, M., Bergquist, J., Nyholm, L. and Markides, K. E., A simple and robust 
conductive graphite coating for sheathless electrospray emitters used in capillary electrophoresis/mass 
spectrometry. Rapid Comm. Mass Spectrom. 15 (2001) 1997. 
 
Nishikawa, M., Tsuchihashi, H., Miki, A., Katagi, M., Schmitt, G., Zimmer, H., Keller, Th. and Aderjan, 
R., Determination of ethyl glucuronide, a minor metabolite of ethanol, in human serum by liquid 
chromatography−electrospray ionization mass spectrometry. J. Chromatogr. B 726 (1999) 105. 
 
Nist Chemistry WebBook, NIST Standard reference database number 69 - July 2001 release, 
http://webbook.nist.gov/chemistry/. 
 
Olivares, J.A., Nguyen, N.T., Yonker, C.R. and Smith, R.D., On-line mass spectrometric detection for 
capillary zone electrophoresis. Anal. Chem. 59 (1987) 1230. 
 
Osman, M., Chandrasekaran, A., Chan, K., Scatina, J., Ermer, J. Cevallos, W. and Sisenwine, S., 
Metabolic disposition of 14C-bromfenac in healthy male volunteers. J. Clin. Pharmacol. 38 (1998) 744.  
 
Pacifici, R., Pichini, S., Altieri, I., Caronna, A., Passa, A. R. and Zuccaro, P., High-performance liquid 
chromatographic-electrospray mass spectrometric determination of morphine and its 3- and 6-
glucuronides: Application to pharmacokinetic studies. J. Chromatogr. B 664 (1995) 329-334. 
 
Paul, D., Standifer, K.M., Inturrisi, C.E. and Pasternak, G.W., Pharmacological characterization of 
morphine-6-β-glucuronide, a very potent morphine metabolite. J. Pharmacol. Exp. Ther. 251 (1989) 477. 
 
Perchalski, R.J.; Yost, R.A.; Wilder, B.J., Structural elucidation of drug metabolites by triple-quadrupole 
mass spectrometry. Anal. Chem. 54 (1982) 1466. 
 
Perel, J.M., McMillan Snell, M., Chen, W. and Dayton, P.G., A study of structure-activity relationships in 
regard to species difference in the phenylbutazone series. Biochem. Pharmacol. 13 (1964) 1305-1317. 
 
Polettini, A. and Huestis, M.A., Simultaneous determination of buprenorphine, norbuprenorphine, and 
buprenorphine-glucuronide in plasma by liquid chromatography−tandem mass spectrometry. J. 
Chromatogr. B 754 (2001) 447. 
 
Prakash, C. and Soliman, V., Metabolism and excretion of a novel antianxiety drug candidate, CP-93,393, 
in Long Evans rats. Drug Metab. Dispos. 25 (1997) 1288. 
 
Qu, J., Wang, Y., Luo, G. and Wu, Z., Identification and determination of glucuronides and their 
aglycones in Erigeron breviscapus by liquid chromatography−tandem mass spectrometry. J. Chromatogr. 
A 928 (2001) 155. 
 
Rao, R., http://www.thermofinnigan.com 
 
Robb, D.P., Covey, T.R. and Bruins, A.P., Atmospheric pressure photoionization: an ionization method 
for liquid-chromatogaphy mass spectrometry. Anal. Chem. 72 (2000) 3653. 
 
Rosenborg, J., Larsson, P., Tegnér, K. and Hallström, G., Mass balance and metabolism of [3H]formoterol 
in healthy men after combined i.v. and oral administration-mimicking inhalation. Drug Metab. Dispos. 27 
(1999) 1104. 
 
 54
Rudewicz, P., Straub, K.M., Rapid structure elucidation of catecholamine conjugates with tandem mass 
spectrometry. Anal. Chem. 58 (1986) 2928. 
 
Sanaullah and Bowers, L.D., Facile synthesis of [16,16,17-2H3]-testosterone, -epitestosterone and their 
glucuronides and sulfates. J. Steroid Biochem. Molec. Biol. 58 (1996) 225. 
 
Schaber, G., Wiatr, G., Wachsmuth, H., Dachtler, M., Albert, K., Gaertner, I. and Breyer-Pfaff, U., 
Isolation and identification of clozapine metabolites in patient urine. Drug Metab. Dispos. 29 (2001) 9. 
 
Schupke, H., Hempel, R., Eckardt, R. and Kronbach, T., Identification of talinolol metabolites in urine of 
man, dog, rat and mouse after oral administration by high-performance liquid chromatography-
thermospray tandem mass spectrometry. J. Mass Spectrom. 31 (1996) 1371. 
 
Schänzle, G., Li, S., Mikus, G. and Hofmann, U., Rapid, highly sensitive method for the detemination of 
morphine and its metabolites in body fluids by liquid chromatography−mass spectrometry. J. Chromatogr. 
B 721 (1999) 56. 
 
Shia, J. and Wang, C.-H., Applications of multiple channel electrospray ionization sources for biological 
sample analysis. J. Mass Spectrom. 32 (1997) 247. 
 
Shimada, K., Mitamura, K. and Nakatani, I., Characterization of monoglucuronides of vitamin D2 and 25-
hydroxyvitamin D2 in rat bile using high-performance liquid chromatography-atmospheric pressure 
chemical ionization mass spectrometry. J. Chromatogr. B. 690 (1997) 348. 
 
Shockcor, J.P., Unger, S.E., Wilson, I.D., Foxall, P.J.D., Nicholson, J.K. and Lindon, J.C., Combined 
HPLC, NMR spectroscopy, and ion-trap mass spectrometry with application to the detection and 
characterization of xenobiotic and endogenous metabolites in human urine. Anal. Chem. 68 (1996) 4431. 
 
Shore, L.J., Fenselau, C., King, A.R. and Dickinson, R.G., Characterization and formation of the 
glutathione conjugate of clofibric acid. Drug Metab. Dispos. 23 (1995) 119-123. 
 
Shou, W.Z., Pelzer, M., Addison, T., Jiang, X. and Naidong, W., An automatic 96-well solid phase 
extraction and liquid chromatography-tandem mass spectrometry method for the analysis of morphine, 
morphine-3-glucuronide and morphine-6-glucuronidde in human plasma. J. Pharm. Biomed. Anal. 27 
(2002) 143. 
 
Sidelmann, U., Bjørnsdottir, I., Shockcoor, J.P., Hansen, S.H., Lindon, J.C. and Nicholson, J.K., Directly 
coupled HPLC-NMR and HPLC-MS approaches for the rapid characterisation of drug metabolites in 
urine: application to the human metabolism of naproxen. J. Pharm. Biomed. Sci. 24 (2001) 569. 
 
Sinz, M.W. and Remmel, R.P., Isolation and characterization of a novel quaternary ammonium-linked 
glucuronide of lamotrigine. Drug Metab. Dispos. 19 (1991) 149. 
 
Slatter, J.G., Feenstra, K.L., Hauer, M.J., Kloosterman, D.A., Parton, A.H., Sanders, P.E., Scott, G. and 
Speed, W., Metabolism of the bisphosphonate ester U-91502 in rats. Drug Metab. Dispos. 24 (1996) 65. 
 
Slawson, M.H., Crouch, D.J., Andrenyak, D.M., Rollins, D.E., Lu, J.K. and Bailey, P.L., Determination 
of morphine, morphine-3-glucuronide and morphine-6-glucuronide in plasma after intravenous and 
intrathecal morphine administration using HPLC with electrospray ionization and tandem mass 
spectrometry. J. Anal. Toxicol. 23 (1999) 468. 
 
Smith, R.D., Barinaga, C.J and Udseth, H.R., Improved electrospray ionization interface for capillary 
zone electrophoresis−mass spectrometry. Anal. Chem. 60 (1988) 1948. 
 
Tang, W. and Abbot, F.S., Bioactivation of a toxic metabolite of valproic acid, (E)-2-propyl-2,4-
pentadienoic acid, via glucuronidation. LC/MS/MS characterization of the GSH-glucuronide 
diconjugates. Chem. Res. Toxicol. 9 (1996) 517. 
 
 55
Tephly, T.R. and Burchell, B., UDP-glucuronosyltransferases: a family of detoxifying enzymes. Trends 
Pharmacol. Sci. 11 (1990) 276. 
 
Tjernberg, A., Edlund, P.O. and Norén, B., Screening of eltanolone metabolites in dog urine by anion-
exchance/reversed-phase liquid chromatography and mass spectrometry. J. Chromatogr. B 715 (1998) 
395. 
 
Tukey, R.H. and Strassburg, C.P., Human UDP-glucuronosyltransferases: Metabolism, expression, and 
disease. Annu. Rev. Pharmacol. Toxicol. 40 (2000) 581. 
 
Tyrefors, N., Hyllbrant, B., Ekman, L., Johansson, M. and Långström, M., Determination of morphine, 
morphine-3-glucuronide and morphine-6-glucuronide in human serum by solid-phase extraction and 
liquid chromatography-mass spectrometry with electrospray ionisation. J. Chromatogr. A 729 (1996) 279. 
 
Weinshilboum, R. and Otterness, D., Sulfotransferase enzymes, in Conjugation-deconjugation reactions 
in drug metabolism and toxicity, Kauffmann, F.C. (Ed.) Springer-Verlag, Berlin-Heidelberg (1994) 45-
78. 
 
Wey, A.B., Caslavska, J. and Thormann, W., Analysis of codeine, dihydrocodeine and their glucuronides 
in human urine by electrokinetic capillary immunoassays and capillary electrophoresis−ion trap mass 
spectrometry. J. Chromatogr. B 895 (2000) 133. 
 
Whitehouse, G. M., Dreyer, R. N., Yamashita, M. and Fenn, J. B., Electrospray interface for liquid 
chromatographs and mass spectrometers. Anal. Chem. 57 (1985) 675. 
 
Wikberg, T. Ottoila, P. and Taskinen, J., Identification of major urinary metabolites the catechol-O-
methyltransferase inhibitor entacapone in the dog. Eur. J. Drug. Metab. Pharmacokinet. 18 (1993) 359. 
 
Wittig, J., Herderich, M., Graefe, E.U. and Veit. M., Identification of quercetin glucuronides in human 
plasma by high-performance liquid chromatography-tandem mass spectrometry. J. Chromatogr. B 753 
(2001) 237. 
 
Yamasita, M. and Fenn, J.B., Electrospray ion source. Another variation on the free-jet theme. J. Phys. 
Chem. 88 (1984a) 4451. 
 
Yamasita, M. and Fenn, J.B., Negative ion production with the electrospray ion source. J. Phys. Chem. 88 
(1984b) 4671. 
 
Yang, Y., Griffits, W.J., Midtvedt, T., Sjövall, J., Rafter, J. and Gustafsson, J.-Å., Characterization of 
conjugated metabolites of benzo[a]pyrene in germ-free rat urine by liquid chromatography/electrospray 
tandem mass spectrometry. Chem. Res. Toxicol. 12 (1999) 1182. 
 
Yasuda, T., Kano, Y., Saito K.-i. and Ohsawa, K., Urinary and biliary metabolites of daidzin and daidzein 
in rats. Biol. Pharm. Bull., 17 (1994) 1369. 
 
Yoshitsugu, H., Fukuhara, T., Ishibashi, M., Nanbo, T. and Kagi, N., Key fragments for identification of 
positional isomer pair in glucuronides from the hydroxylated metabolites of RT-3003 (Vintoperol) by 
liquid chromatography/electrospray ionization mass spectrometry. J. Mass Spectrom. 34 (1999) 1063. 
 
Yu, K. and Balogh, M., http://www.waters.com 
 
Yu, Z. and Westerlund, D., Direct injection of large volumes of plasma in a column-switching system for 
the analysis of local anaesthetics. I. Optimization of semi-permeable surface precolumns in the system 
and characterization of some interference peaks. J. Chromatogr. A 725 (1996a) 137.  
 
Yu, Z. and Westerlund, D., Direct injection of large volumes of plasma in a column-switching system for 
the analysis of local anaesthetics. II. Determination of bupivacaine in human plasma with alkyl-diol silica 
precolumn. J. Chromatogr. A 725 (1996b) 149. 
 56
 
Zhang, G.-Q., McKay, G., Hubbard, J.W. and Midha, K. K., Application of electrospray mass 
spectrometry in the identification of intact glucuronide and sulphate conjugates of clozapine in rats. 
Xenobiotica 26 (1996) 541. 
 
Zhang, J.Y., Wang, Y., Dudkowski, C., Yang, D., Chang, M., Yuan, J., Paulson, S.K. and Breau, A.P., 
Characterization of metabolites of Celecoxib in rabbits by liquid chromatography/tandem mass 
spectrometry. J. Mass Spectrom. 35 (2000) 1259. 
 
Zheng, M., McErlane, K.M. and Ong, M.C., High-performance liquid chromatography-mass 
spectrometry analysis of morphine and morphine metabolites and its application to a pharmacokinetic 
study in male Sprague-Dawley rats. J. Phar. Biomed. Anal. 16 (1998) 971. 
 
Zhou, S. and Cook, K.D., Protonation in electrospray mass spectrometry: wrong-way-round or right-way-
round? J. Am. Soc. Mass Spectrom. 11 (2000) 961. 
 
Zuccaro, P., Ricciarello, R., Pichini, S., Pacifici, R., Altieri, I., Pellegrini, M. and D’Ascenzo, G., 
Simultaneous determination of heroin, 6-monoacetylmorphine, morphine, and its glucuronides by liquid 
chromatography-atmospheric pressure ionspray-mass spectrometry. J. Anal. Toxicol. 21 (1997) 268. 
 
 
